Mechanism of 4-Hydroxynonenal induced toxicity in Jurkat CD4+ T lymphocytes. by Chang, Wei Yuan
University of Louisville 
ThinkIR: The University of Louisville's Institutional Repository 
Electronic Theses and Dissertations 
5-2006 
Mechanism of 4-Hydroxynonenal induced toxicity in Jurkat CD4+ 
T lymphocytes. 
Wei Yuan Chang 
University of Louisville 
Follow this and additional works at: https://ir.library.louisville.edu/etd 
Recommended Citation 
Chang, Wei Yuan, "Mechanism of 4-Hydroxynonenal induced toxicity in Jurkat CD4+ T lymphocytes." 
(2006). Electronic Theses and Dissertations. Paper 232. 
https://doi.org/10.18297/etd/232 
This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The University of Louisville's 
Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized 
administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the 
author, who has retained all other copyrights. For more information, please contact thinkir@louisville.edu. 
MECHANISM OF 4-HYDROXYNONENAL INDUCED TOXICITY IN JURKAT 
CD4+ T LYMPHOCYTES 
By 
Wei Yuan Chang 
M.S. University of Louisville, 2004 
A Dissertation 
Submitted to the Faculty of the 
Graduate School of the University of Louisville 
in Partial Fulfillment of the Requirements 
for the Degree of 
Doctor of Philosophy 
Department of Pharmacology and Toxicology 












Wei Yuan Chang 

























       
 
 
       
 
 
       
 
 






This dissertation is dedicated to my Lord and grandparents 
Mr. Chin-Huan Kuo 
and 
Mrs. Yang Hsueh-Chen Kuo 
who have given invaluable Salvation, love and enable me to complete this project 
111 
ACKNOWLEDGMENTS 
I would like to express my gratitude to Professors Theresa S. Chen and Barve S. 
Shirish for their continued guidance, leadership, and support throughout this work. I 
would like to indicate my appreciation to Marcia Liu for his assistance during the course 
of this project. Thanks are also due to Professors Walter M. Williams, Craig J. McClain, 
Donald E. Nerland and Frederick W. Benz for their contributions as members of my 
dissertation committee. Special thanks to go Professor Herbert T. Nagasawa for 
providing the test compound that allowed this project to proceed. I would also like to 
thank the Department of Pharmacology and Toxicology faculty, staff, and graduate 
students, for giving me the opportunity to work with them and prepare for my future. 
Last, I would like to thank Rev. Winston Wen, the pastor of Taiwanese Presbyterian 
Church, and Rev. Vincent Kuo, my uncle and the pastor of Redeemer Church PCA. 




MECHANISM OF 4-HYDROXYNONENAL INDUCED TOXICITY IN JURKAT 
CD4+ T LYMPHOCYTES 
Wei-Yuan Chang 
April 24, 2006 
Oxidative stress-induced immunosuppression could be due to a decrease in 
CD4+ T lymphocyte activation or proliferation. 4-Hydroxynonenal (HNE), an end 
product of lipid peroxidation, and its protein adducts act as markers of oxidative stress. 
In this study, the effects of HNE on a human CD4+ Jurkat T cells were examined. 
Systematic determinations of the effects of HNE on cytotoxicity, Akt and protein 
phosphatase 2A(PP2A)activation, FaslFasL-mediated apoptotic signaling, methionine 
adenosyltransferase (MAT) II activity, MAT 2A and c-Myb expression and cellular 
glutathione (GSH) and S-adenosylmethionine (SAMe) levels were performed. The 
results showed that HNE induced cytotoxicity, downregulated Akt and upregulated 
PP2A activation, and resulted in enhanced FasL expression, death-inducing signaling 
complex (DISC) formation, Fas-associated death domain (FADD) recruitment, and 
caspases cleavages, and comitantiy decreased c-FLIPs expression. Further, HNE-
induced cytotoxicity and lost of survival is associated with GSH depletion in a 
threshold phenomena and can be potentiated by inhibition of GSH synthesis. In 
addition, HNE toxicity was also involved with SAMe metabolism by inhibition of 
MAT II activity, MAT 2A and c-Myb expression and which resulted in decreases in 
v 
SAMe concentrations and lead to caspase-3 dependent apoptosis. 2(RS)-n-
propylthiazolidine-4(R)-carboxylic acid (PTCA), a GSH precursor, restored GSH and 
SAMe as well as upregulated Akt and MAT activities, protected against HNE toxicity. 
It was concluded that HNE toxicity may be due to an Akt regulated, Fas/FasL-
medoated, and caspase-8 dependent apoptotic signaling pathway, that HNE toxicity is 
associated with GSH depletion and can be prevented by a GSH precursor, and that 
MAT and SAMe may be involved in HNE toxicity. 
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Oxidative stress associated with intracellular cell signaling is an important 
pathological factor in several immunosuppressive diseases, such as diabetes mellitus, 
chronic hepatis C, chronic alcoholism and AIDS (Smith et aI., 1976; MacGregor, 1986; 
Raju et aI., 1994; Sen, 1997; Kajimoto et aI., 2002). The balance of reactive oxygen 
species (ROS) and antioxidants regulate both cell activation and cell death in T-cell-
based immunodeficiency, allergy, and autoimmune disease by affecting T cell function 
and numbers (Serafini, 2000). The goals of this project are to: (1) elucidate the 
mechanisms involved in oxidative stress induced suppression of T lymphocytes, and 
(2) develop potential therapeutic interventions for oxidative stress related diseases. 
Oxidative stress and immune dysfunction 
Oxidative stress and disease 
Clinically, oxidative stress has been shown to be associated with decreased 
immune function in aging and in diseases (Shellito and Olariu, 1998; Calabrese et aI., 
2002). Oxidative stress results in the production ofROS, such as superoxide radicals, 
hydroxyl radicals, and hydrogen peroxide (H20 2), and leads to an imbalance of pro-
oxidant-antioxidant status. ROS is known to playa role in chronic inflammation and 
human immunodeficiency virus (HI V) infection in immune cells (Cederbaum, 1989; 
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Nakamura et ai., 2002). The association of oxidative stress with HIV infection was 
originally implied from the finding of reduced levels of glutathione (GSH) in the 
plasma and lymphocytes of AIDS patients (Nakamura et ai., 2002; Shan et ai., 1990). 
Alcoholic patients have significantly reduced numbers of CD4+ T lymphocytes in the 
periphery and the spleen, as well as a reduction in immune function (Shellito and 
Olariu, 1998). In acute or chronic active hepatitis C, oxidative stress increases free 
radical generation and membrane lipid peroxidation in the liver and peripheral blood 
mononuclear cells (Navas et ai., 1998). These are associated with hepatic damage, 
GSH depletion, and increased serum malondialdehyde (MDA) and 4-hydroxynonenal 
(HNE) (Esterbauer et aI., 1991). Any process that interferes with the ability ofT cell 
division is likely to have major implications for the effectiveness of an immune 
response (Hamilos and Wedner, 1985; Droge et ai., 1986). 
T cells and immunosuppression 
The immune system is generally divided into two categories: innate and 
adaptive (acquired) immunity. Adaptive immunity is characterized by the responses of 
antigen-specific lymphocytes to antigen. Lymphocytes are critical cellular components 
for the adaptive immune response, and regulate both the humoral and cell mediated 
immunity, which resist invaders such as viruses that reproduce within the cells of the 
body. T lymphocytes are further classified by glycoprotein receptors present on the 
cell surface into CD8+ T lymphocytes (also known as cytotoxic/killer T cells) and 
CD4+ T lymphocytes (also known as helper T cells). Upon antigen presentation by an 
antigen presenting cell (APC), all these cell types act differently to combat the 
presented antigen. While stimulation of CD8+ T cells activates them to kill the target 
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antigen, stimulation of CD4+ T cells leads to their activation and clonal expansion 
(Droge et aI., 1986). CD4+ T lymphocytes are the main regulators of both humoral and 
cell-mediated immunity. They mediate the immunogenic response through release of 
cytokines signaling other immune cells to kill the target antigen (Brunner et aI., 2003). 
Most importantly, the loss of CD4+ T lymphocytes has been clearly related to 
impairment of several immune functions and ensuing immunosuppression. 
Lipid peroxidation and CD4+ T lymphocyte death 
There is increasing evidence that reactive aldehydic molecules generated as a 
consequence oflipid peroxidation are causally linked to most of the pathophysiological 
effects associated with oxidative stress in cells and tissues (Uchida, 2003). Lipid 
hydroperoxides are derived from unsaturated phospholipids, glycolipids, and 
cholesterol. They are prominent intermediates of peroxidative reactions induced by 
activated species such as hydroxyl radical, lipid oxyl or peroxyl radicals, singlet 
oxygen, and peroxynitrite (Fig. 1). Among them, MDA and HNE are clinically and 
structurally relevant lipid peroxides (Kalinich et aI., 1999). HNE is considered to be a 
physiological messenger molecule signaling for various cellular responses (Uchida, 
2003). HNE may playa central role in the down-regulation of cell proliferation and in 
the modulation ofT cell differentiation (Liu et aI., 2000). In addition, HNE has been 
detected in several oxidative stress related immune diseases including diabetes 
mellitus, alcoholism, and atherosclerosis (Romero et aI., 1998). Studies suggest that 
the formation of HNE and HNE-protein conjugates is a marker of oxidative stress in 
tissues or cells (Kruman et aI., 1997). It was found that after chronic administration of 




Fig. 1. Structures ofHNE and MDA. Uchida, K. (2003) 
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in the hippocampus and cerebellum, which correlated with decreased GSH reductase 
activity in these regions (Calabrese et aI., 2002). The results of several clinical studies 
suggest that alcoholism, HIV -, and HCV -infected patients were all observed to have 
enhanced lipid peroxidation with high plasma MDA and HNE concentrations 
(Haughey et aI., 2004; Rigamonti et aI., 2003). Recent findings show HNE induced 
apoptotic cell death with concomitantly decreased GSH and glutathione disulfide 
(GSSG) in human lymphoma cells (Jurkat) (Liu et aI., 2000). Other results, along with 
our studies, suggest that oxidative stress induced by HNE caused T lymphocyte 
dysfunction. Hence, it is essential to understand the underlying mechanism involved in 
the cytotoxic effects ofHNE on CD4+ T cells. 
Fas-mediated cell death 
T lymphocyte death is essential for proper function of the immune system. 
Under normal physiological as well as pathophysiological conditions, T lymphocytes 
undergo activation-induced apoptotic cell death (AICD), which is primarily mediated 
by Fas/FasL dependent signaling (Brunner et aI., 2003). Induction of FasL expression 
has been implicated in drug and stress induced apoptotic death of T lymphocytes 
(Hueber et aI., 2002; Green et aI., 2003). Upon activation, Fas undergoes trimerization 
and initiates the formation of the death-inducing signaling complex (DISC) by 
recruiting the proapoptotic adapter protein Fas-associated death domain (FADD) and 
procaspase-8, also called F ADD-like interleukin I ~-converting enzyme (FLICE) 
(Peter and Krammer, 2003) (Fig. 2). 
Proteolytic activation ofprocaspase-8 is initiated by its recruitment to the DISC 
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Fig. 2. Fas-mediated death signaling. Modified from Peter and Krammer (2003). 
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inhibitory protein (c-FLIP) is an antiapoptotic cytoplasmic protein with sequence 
homology to caspase-8. c-FLIP is unable to undergo cleavage to an active caspase due 
to substitution of a tyrosine for an active site cysteine, and hence can function as a 
dominant-negative inhibitor of caspase-8, thereby preventing Fas-induced apoptosis 
(Hueber et aI., 2002; Green et aI., 2003; Peter and Krammer, 2003). Alternative 
splicing yields multiple isoforms of c-FLIP; two commonly occurring isoforms are 
designated c-FLIPL (long isoform) and c-FLIPs (short isoform) (Krueger et aI., 2001a; 
Tibbetts et aI., 2003). c-FLIP has been shown to play an anti-apoptotic role in a 
number of cell types and elevated c-FLIP expression renders cells resistant to Fas-
induced apoptosis (Krueger et aI., 2001). In fact, the susceptibility ofT lymphocytes to 
Fas-mediated apoptosis correlates with c-FLIP levels, which are elevated during early 
stages of activation but are significantly reduced upon re-stimulation when the T cells 
undergo AICD (Rigamonti et aI., 2003; Irmler et aI., 1997; Uriarte et aI., 2005). The 
molecular mechanisms involved in the regulation of expression of c-FLIP in T 
lymphocytes are not completely understood. 
Oxidative Stress, GSH and SAMe 
GSH, a cysteine-containing tripeptide, plays an important role in the 
circumvention of cellular oxidative stress and the maintenance of intracellular thiol 
redox status (Khanna et aI., 1998; Sen, 1998; Meister, 1989) (Fig. 3). S-Adenosyl-
methionine (SAMe) is a major methyl donor for cellular transmethylation reactions 
involving proteins, nucleic acids, and various lipids, and it functions as an antioxidant. 
SAMe is a GSH synthesis precursor via the transsulfuration pathway and decreases in 
SAMe result in GSH deficiency (Honchel et al., 1992). Chronic alcohol abuse not only 
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results in hepatic SAMe depletion, but is also associated with a decrease in the levels 
of intracellular GSH (Honchel et aI., 1992; Koch et aI., 1991; Wang and Spitzer, 1997; 
Shan et aI., 1990). SAMe is also required for cell proliferation upon activation of T 
lymphocytes, after which both the SAMe pool size and the rate of SAMe utilization 
increase (German et aI., 1983). In Jurkat T cells, GSH content plays an important role 
in the cell cycle, rising steadily from the G 1 phase through the S phase, and reaching a 
maximum at G2/M (Soderdahl et aI., 2003). Clinically, patients with chronic diseases 
such as genitourinary, gastrointestinal, cardiovascular, and musculoskeletal diseases 
including cancer had a marked decrease in total GSH content in the blood (Lang et aI, 
2000). Oxidative stress diseases and the resultant GSH depletion can adversely affect 
normal CD4+ T lymphocyte function, proliferation and survival (Peterson et aI., 1998; 
Hamilos and Wedner, 1985; Droge et aI., 1986). 
CD4 + T cells are the targets of HIV infection, and the decrease of CD4 + T cells 
occurs AIDS. A recovery of the human CD4+ T lymphocyte count was seen in several 
studies after supplementation with antioxidant agents, such as N-acetyl-cysteine 
(NAC), oxothiazolidine carboxylic acid (OTC), and Vitamin E. This finding indicates 
that oxidative stress can affect human CD4+ T lymphocyte survival (Mato et aI., 2002; 
Nakamura et aI., 2002). Our preliminary data showed that NAC rescues CD4+ T cells 
from H202 induced caspase-3 activation and apoptosis, while depletion of GSH by 
buthionine sulfoximine (BSO), which inhibits GSH synthesis, exacerbates it. 2(RS)-n-
Propylthiazolidine-4(R)-carboxylic acid (PTCA) is a sulfhydryl-protected compound 
containing a cyclized form ofL-cysteine (Cys) that can be non-enzymatically 
converted to Cys at physiological pH and room temperature (Nagasawa et aI., 1984) 
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(Fig. 3). PTCA has been shown to attenuate acetaminophen (APAP)- and para-
aminophenol (PAP)-induced hepatic GSH depletion both in mice (Srinivasan et aI., 
2001) and hamsters (Fu, 2001). Whether PTCA can protect against HNE-induced 
cytotoxicity and depletion of GSH and SAMe has not been investigated. Thus, our aim 
is to investigate the role of antioxidants in HNE-induced cytotoxicity in human CD4+ T 
cell immunotoxicity. Further, we plan to explore whether PTCA, a GSH precursor, can 
attenuate HNE-induced decreases in intracellular GSH and SAMe, and thereby prevent 
its cytotoxicity. 
SAMe and MAT II 
SAMe also participates in polyamine biosynthesis and is a precursor for the 
synthesis of GSH through its conversion to Cys via the transsulfuration pathway. As 
vital as GSH is in alleviating endogenous oxidative stress and in functioning as an 
antioxidant, SAMe is known to be absolutely critical for T lymphocytes (German et aI., 
1983). Methionine adenosyltransferase (MAT, also know as S-adenosyl-L-methionine 
synthetase) is the enzyme that catalyzes the formation of SAMe from methionine and 
adenosine triphosphate (ATP) (Cantoni, 1953) (Fig. 4). In mammals, there are two 
genes coding for MAT: MATI A and MAT 2A, and their products are know as MAT 
IIIII and MAT II, respectively (Cantoni, 1953; Lu, 2000). In lurkat T cells, the MAT 
2A gene is highly expressed. Recently, lani et al. in this laboratory have shown that 
inhibition of MAT II activity by cycloleucine leads to a decrease of intracellular SAMe 
levels in lurkat T cells and loss of survival in MOLT -4 and lurkat T cells. Studies 
have shown that T cell activation is associated with increased MAT II expression, and 
the turnover of SAMe in activated lymphocytes is five times greater than other extra-
9 
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Fig. 4. Proposed SAMe synthetic pathway in T lymphocytes. Modified from Lu, S.c. (2000). 
hepatic tissues, suggesting that MAT II and SAMe play important roles in T cell 
activation and survival (German et aI., 1983). Since SAMe deficiency often leads to 
GSH depletion via the transsulfuration pathway, more studies suggest that intracellular 
GSH or the GSH/GSSG ratio may play an important role for the integrity and activity 
of MAT (Shirota et aI., 2002). However, the mechanisms involved in the regulation of 
MAT II activity are not completely understood. 
Decreased MAT activity and expression are found in alcoholic liver disorders 
and viral induced cirrhosis, coinciding with SAMe depletion in both patients and 
animal models (Mato et aI., 2002). It was also shown that administration of BSO, an 
inhibitor of the GSH biosynthesis, leads to a decrease of MAT activity and SAMe in 
rats (Corrales et aI., 1991). Recently, studies demonstrated APAP administration 
rapidly depletes hepatic GSH followed by decreases in MAT activity in mice (Shirota 
et aI., 2002). Similarly, carbon tetrachloride, galactosamine, and hypoxia decrease 
MAT activity in vivo as well (Corrales et aI., 1992; Mato et aI., 1997). These results 
have led us to propose that there is a casual relationship between oxidative stress, 
decreased levels of antioxidants, and inhibition of MAT activity (Fig. 5). However, 
whether MAT is compromised in HNE-induced cytotoxicity in CD4+ T lymphocytes is 
not known. 
Role of c-Myb 
c-Myb is a 75- to 80-kDa protein and is one of the three mammalian Myb 
proteins (A, B and C), all of which function as transcriptional factors that are 
implicated in the regulation of proliferation, differentiation and apoptosis (Oh and 
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2A gene induction, c-Myb expression is induced upon T cell activation and trans-
activates the MAT 2A promoter by binding to the consensus c-Myb binding site 
located at -350 to -333 (Zeng et aI., 2001). c-Myb anti-sense oligonucleotide mediated 
inhibition of c-Myb prior to mitogen or antigen dependent stimulation, inhibits T cell 
proliferation, suggesting an essential role for c-Myb in T cell expansion (Venturelli et 
aI., 1990; Furukawa et aI., 1990). Studies have shown that c-Myb activity is required 
for Akt to act as a survival factor during T cell activation and that the c-Myb gene is 
only regulated by the components of the PI3K pathway (Lauder et aI., 2001). Although 
the effects of c-Myb are well studied in hematopoiesis, the regulation of c-Myb is not 
completely understood. 
Mediators of the survival pathway 
Role of Akt 
The survival signal elicited by Akt, a serine/threonine protein kinase, proceeds through 
several mechanisms, including inactivation of BAD (Datta et aI., 1997; del Peso et aI., 
1997), which is a death enhancer, and caspase-9 (Cardone et aI., 1998), stimulation of 
NF-KB activity, inactivation of the forkhead transcription factor (Kops and Burgering, 
1999), and phosphorylation of apoptosis signal-regulating kinase 1 (ASK1) and 
glycogen synthase kinase 3 (GSK3) (Cross et aI., 1999). In contrast to the activation of 
Akt, associated with its phosphorylation by 3' -phosphoinositide-dependent kinase-1 
(PDK1) (Ouyang et aI., 1999), downregulation of Akt is still not fully understood. 
Apoptosis is a programmed cell death distinct from necrosis and is under the control of 
caspases, a class of cysteine proteases (Cardone et aI., 1998). The putative role of 
apoptotic proteases in the degradation of Akt is less defined, but Akt appears to be a 
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substrate of caspase-3 in vitro, and caspase-3-dependent cleavage of Akt may be 
relevant in detachment-induced and FasL-mediated cell death (Liu et aI., 2000). 
Survival factors were equally important in the regulation of the apoptotic process 
(Uriarte et aI., 2005). Studies have demonstrated that the PI3KJ Akt pathway prevents 
the accumulation of intracellular ROS by regulating the expression of the antioxidant 
enzyme heme oxygenase (HO-I) in dopaminergic PC12 cells (Salinas et aI., 2003). It 
has also been shown that the PI3KJAkt pathway is indispensable for the survival of 
human CD4+ T lymphocytes (Salinas et aI., 2003). Studies have demonstrated that Akt 
was significantly inactivated and down-regulated in H20 2-induced CD4+ T cell 
apoptosis (Khanna et aI., 1998). However, little is known about the mechanism(s) 
employed by the apoptotic machinery to down-regulate Akt survival signals. 
Therefore, we used HNE as an oxidative stimulus to examine the role that Akt kinase 
plays in lurakt T cell survival during oxidative stress. Another aim ofthis project was 
to determine whether there is a direct link between the antioxidants GSH and SAMe 
and the regulation of survival factor (Akt). In addition, we investigated the possible 
protective effect of increasing GSH concentrations with PTCA on Akt inactivation. 
Akt and PP2A 
Protein phosphatase-2A (PP2A) is one of four major cytoplasmic 
serine/threonine phosphatases that are known to play an important role in the regulation 
of diverse cellular proteins, including metabolic enzymes, hormone receptors, kinase 
cascades, and cell growth. PP2A is a heterotrimer consisting of a catalytic subunit "C" 
(36 kDa), a regulatory subunit "A" (60-kDa) and one of several "B" subunits (54, 
55, 72, and 130 kDa) (Ivaska, et aI., 2002; Van Kanegan et al., 2005). The physiologic 
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importance of these forms and their regulation by hormones or extracellular stimuli has 
not been established. In vitro studies indicate that the catalytic subunit ofPP2A is 
regulated by a variety of post-translational modifications, including phosphorylation 
(Chen et al., 1992) and methylation. PP2A has been shown to be the major 
phosphatase targeting and inactivating Akt in vitro (Van Kanegan et al., 2005), and 
several reports have documented the complex formation between these two enzymes 
(Ivaska et aI, 2002; Resjo et al., 2002). A PP2A inhibitor, okadaic acid, has been found 
to activate Akt in lurkat T cells treated with HNE, suggesting that PP2A is a major 
antagonist ofPDK1 in the downregulation of Akt (Liu et al., 2003). It is likely that 
Akt modulation involves direct dephosphorylation of Akt activity by PP2A (Fig. 6); 
however, the mechanism is not clear. An aim of this project was to investigate the 
mechanism. 
Akt and c-FLIPs 
Although several anti-apoptotic functions of Akt have been identified in T 
lymphocytes, the potential role of Akt in regulating c-FLIP expression and the impact 
on subsequent apoptotic signaling has not been examined. Through sensitizing Fas-
mediated death signals, the Akt activation was reported to promote c-FLIP expression 
in endothelial cells (Suhara et ai., 2002, 2004) (Fig. 7). c-FLIP expression has been 
shown to regulate Fas-mediated apoptosis of activated T cells through competing with 
caspase-8 for recruiting to the DISC (Krueger et al., 2001a; Irmler et al., 1997). 
Studies have shown that inhibition of Akt, using either a PI3 kinase inhibitor or a 
selective Akt inhibitor, up-regulates FasL gene expression, and downregulates c-FLIP 
16 
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Fig. 6. Proposed effects ofHNE on Akt and PP2A in regulation of survival signaling. 
























Fig. 7. Proposed roles of Akt and c-FLIPs in Fas-mediated death signaling. Modified 
from Peter and Krammer (2003). 
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expression (Uriarte et aI., 2005). However, regulation of c-FLIP expression in T cells 
induced by HNE is not completely understood. 
Based on these findings, our working hypothesis is that HNE is involved in 
chronic disease induced oxidative damage in CD4+ T lymphocyte. We further propose 
that HNE, as well as oxidative stress, involves depletion of cellular GSH and SAMe, 
and that downregulation of Akt kinase and MAT II activity leading to an enhanced 
susceptibility of CD4+ T lymphocytes to Fas-mediated apoptotic death. The overall 
objectives of this proposal are to (1) elucidate the cellular and molecular mechanism(s) 
involved in HNE-induced CD4+ T cell depletion and (2) develop possible therapeutic 
interventions for preventing CD4+ T cell depletion and following immunosuppression 
in HIV/HCV infected patients. The specific aims of this proposal are: 
1. Determine the toxic effects of 4-hydroxynonenal (HNE) on human CD4+ T 
lymphoma lurkat cells and its association with immune (dys)regulation. 
2. Determine the expression ofFas on Jurkat T lymphocytes exposed to HNE and 
correlate Fas expression with increased susceptibility to Fas-mediated signaling 
and death. 
3. Determine the effects ofHNE on cellular antioxidant status by measuring 
cellular GSH and SAMe concentrations. 
4. Investigate the role of Akt-mediated apoptosis in HNE-induced cytotoxicity in 
Jurkat T cells. 
5. Determine whether the overall catalytic activity ofPP2A and the involvement 
ofPP2A are upregulated via HNE-mediated decreases of Akt activation in 
Jurkat T cells. 
19 
6. Determine the effect ofHNE on lurkat T lymphocytes MAT II expression and 
activity, SAMe concentrations and metabolism and Fas-mediated apoptotic cell 
death. 
7. Determine the effect ofHNE on c-Myb, the transtription activator of MAT 2A, 
expression in lurkat T cells. 
8. Evaluate the efficacy of GSH enhancing precursors against HNE-induced 




HNE-INDUCED CYTOTOXICITY IN CD4+ T LYMPHOCYTES 
INTRODUCTION 
The studies of HNE toxicity in human CD4+ T lymphocytes described in this 
chapter were designed to test cellular and molecular mechanisms involved in HNE-
induced T cell death. The effect of HNE on cytotoxicity was studied and the 
involvement of Fas-FasL mediated apoptotic death was further evaluated. Necrosis 
was assessed by elevations in LDH activity and trypan blue count and apoptosis was 
assessed by an increase in DNA fragmentation. To evaluate the involvement of Akt, a 
survival factor, in apoptotic cell death, the effects of HNE on Akt kinase activation 
were examined. To evaluate the involvement of FasL in apoptotic cell death, the 
effects of HNE on FasL expression, FADD recruitment and DISC formation were 
examined. To evaluate the involvement of caspase in apoptosis, the effects of HNE on 
caspase-8 activity, procaspase-8 cleavage and its dependent apoptosis were examined. 
Finally, to evaluate the role of anti-apoptotic factors in apoptosis, the effect of HNE on 
the expression of c-FLIPs was examined. While the main focus of the study was HNE, 
the effect of MDA, the clinically relevant lipid peroxidation end product, was also 
examined. 
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MA TERIALS AND METHODS 
Cell culture 
Jurkat, clone E6-1, a human CD4+ T cell leukemia cell line, was obtained from 
ATCC (American Type Culture Collection, Rockville, MD). Jurkat cells were grown 
in RPMI 1640 supplemented with 10% fetal bovine serum, 10 Vlml penicillin, and 10 
f,lg/ml streptomycin in a 37°C 5% CO2 incubator. Jurkat cells were resuspended at 1 x 
106 cells/ml during treatment. 
Chemicals 
HNE and MDA were kindly provided by Dr. Sanjay Srivastava, Department of 
Internal Medicine. HNE was synthesized as its dimethylacetal starting from 
dimethyl acetal of fumaraldehyde as described previously (Chandra et aI., 2004). 
Phytohemoagglutinin (PHA), Nonidet P-40, sodium orthovanadate, sodium 
pyrophosphate, N,N-dimethylformamide (DMF), sodium dodecyl sulfate (SDS), 
aprotinin, leupeptin, benzamidine, and potassium fluoride were purchased from Sigma 
Chemical Co. (St. Louis, MO). FADD was purchased from Cell Signaling (Beverly, 
CA). Protein AlG agarose and antibodies Fas (B-lO), Fas-L (C-178) and p-Actin were 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-FLIPy/8 (191-209) 
antibody and caspase-8 inhibitor II were purchased from Calbiochem (La Jolla, CA). 
Phospho-Akt (Ser 473), total Akt antibodies were purchased from Cell Signaling 
(Beverly, CA). Goat anti-rabbitlanti-mouse/anti-rat antibodies conjugated with horse-
radish peroxidase, which were used as secondary antibodies in immunoblotting, were 
purchased from Bioscience International (Rockville, MD). RPMI 1640 dry powdered 
medium was pursued from HyClone Co. (Logan, VT). Fetal bovine serum, 
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penicillinistI1eptomycin, and trypan blue were purchased from Invitrogen Co. (Grand 
Island, NY). Phenylmethylsulfonyl fluoride (PMSF) was obtained from Boehringer 
Mannheim Co. (Indianapolis, IN). p-Glycerophosphate was purchased from TCI 
America (Portland, OR). Phosphate buffered saline (PBS) was obtained from BD 
Biosciences Pharmigen (San Diego, CA). 
DNA fragmentation ELISA assay 
To measure cell apoptosis, the treated Jurkat T cells were lysed after HNE 
treatment for 6 h. DNA fragmentation was quantified using the Cell Death ELISA kit 
(Roche, Indianapolis, IN). The assay was based on the quantitative sandwich-enzyme-
immunoassay principle using mouse monoclonal antibodies directed against DNA and 
histones to determine the presence of mono-and oligonucleosomes in the cytoplasmic 
fraction of cttlllysates. The lysate was centrifuged at 200 x g for 10 min and 20 [!l of 
the cytoplasmic fraction was transferred to the streptavidin coated micro titer plate. A 
mixture of arn.ti-histone-biotin labeled antibody and anti-DNA peroxidase conjugated 
antibody was added and the plate incubated for 2 h. After removal of the antibodies by 
a washing step, the amount of nucleosome-bound fragmented DNA was quantified 
photometrically by the peroxidase retained in the immunocomplex, using ABTS (9,2, 
2' -Azino-di [3-ethylbenzthiazolin-sulfonate]) as a substrate. The results were obtained 
as optical density values and expressed as fold over untreated cells. 
Akt [pS473] ELISA assay 
Treated Jurkat T cells were lysed at 0.5 to 6 h for determination of Akt. The 
concentrati01l1 of Akt which was phosphorylated at serine residue 473 was determined 
by ELISA (Akt [pS473] kit; BioSource International Inc., Camarillo, CA). A 
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monoclonal antibody specific for Akt has been coated onto the wells of the microtiter 
strips, standards, samples or positive controls were added to appropriate wells and the 
plate was incubated for 2 h. After washing, a rabbit antibody, specific for Akt 
phosphorylated at serine 473, was added to the wells and incubated for 1 h followed by 
the addition of a horseradish peroxidase-labeled anti-rabbit IgG (anti-rabbit IgG-HRP) 
working solution to conjugate the antibody for 30 min. After a third incubation and 
washing to remove all the excess anti-rabbit IgG-HRP, 100 /-ll of substrate solution was 
added, which. was acted upon by the bound enzyme to produce color. After 20 to 25 
min, 100 /-ll 0f stop solution was added and the absorbance was measured at 450 nm. 
The absorbance of the standards was plotted against concentration. The Akt [pS473] 
concentration for unknown samples and controls were calculated from the standard 
curve. 
PP2A enzymatic activity assay 
PP2A enzymatic activity was assessed following PP2A immunoprecipitation 
using a malachite green based phosphatase assay (PP2A Immunoprecipitation 
Phosphatase Assay Kit; Upstate). Following HNE treatment, cells were lysed with 
phosphatase extraction buffer (20mM imidazole-HCI, 2mM EDTA, 2mM EGTA, pH 
7.0 with 10 I-Lg/ml each of aprotinin, leupeptin, antipain, soybean trypsin inhibitor, 1 
mM phenylIl1lethylsulfonyl fluoride (PMSF), and 1 mM benzamidine) and the lysate 
(450 /-lg of protein/per sample) was incubated with 4 /-lg of an anti-PP2A antibody 
(clone ID6; Upstate) and 35 /-ll of protein A agarose slurry at 4°C with constant 
rocking for 2 h. Agarose-bound immune complexes were collected and, following 
washing three times with 700 /-ll TBS and 500 /-ll optimized Ser/Thr buffer (final wash), 
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were resuspended in 20 !J,l Serffhr buffer. Phosphopeptide (amino acid sequence: K-
R-pT-I-R-R) was added (60 I .. d) as a substrate for PP2A, and samples were incubated at 
30°C in a shaking incubator for 10 minutes. Supernatants (25 !J,l) were transferred to a 
96-well platte, and released phosphate was measured by adding 100 !J,l malachite green 
phosphate detection solution. Color developed for 15 minutes before reading the plate 
at 650 nm. The absorbance of the reactions was corrected by subtracting the 
absorbance of blank (25 )..11 Serffhr buffer). Phosphate concentrations were calculated 
from a standard curve created using serial dilutions of a standard phosphate solution (0 
to 2,000 pm<Dl). Data were normalized to protein concentration and PP2A activity 
expressed as pmol phosphate/ )..1g protein/1 0 min. 
Caspase-8 activity assay 
To measure caspase-8 activity, cytoplasmic extracts were prepared from lurkat 
cells treated for 6 h, and analyzed using the CASPASE-8 Colorimetric Activity Assay 
kit (Chemicon International, Temecula, CA). The assay was based on 
spectophotometric detection of the chromophore p-nitroaniline (pNA) after cleavage 
from the caspase-8 specific substrate IETD-pNA. The free pNA was quantified using a 
microtiter plate reader at 405 nm. In brief, cell lysate was centrifuged at 10,000 x g for 
5 min and 45 !J,l of the cytoplasmic fraction was transferred to a fresh tube and put on 
ice. A mixture of assay buffer (5X), sample supernatant, caspase-8 substrate and 
distilled water were added and the plate incubated for 2 h. Read samples at 405 nm 
with a microtiter plate reader. The optical density values obtained with the CASP ASE-
8 Colorimetric Activity Assay kit for unknown samples were calculated from the 
standard curve. Comparison of the absorbance of pNA from an apoptotic sample with 
25 
an untreated control allows determination of the fold increase in caspase-8 activity. 
The definition of one unit is the amount of enzyme that will cleave 1.0 nmol of the 
colorimetric substrate Ac-IETD- pNA per hour at 37°C under saturated substrate 
concentrations. The results were expressed as activity units per mg of protein. 
RNA isolation and real time peR analysis 
Reverse transcriptase polymerase chain reaction (RT-PCR) assays were used to 
assess FasL mRNA levels in Jurkat cells. Total RNA was isolated from treated cells 
after 1 h, using TRIZOL (Invitrogen, Carlsbad, CA). For real time PCR, the first 
strand cDNA was synthesized using TaqMan Reverse transcription reagents (Applied 
Biosystems). The reverse transcription was carried out using IX Taqman RT buffer, 
5.5 rnM MgCh, 500 /-lM of each dNTP, 2.5 /-lM random hexamer, 8 U of RNase 
inhibitor and 25 U of Multiscribe Reverse Transcriptase with 200 ng of total RNA. 
The RT conditions were 10 min at 25°C, 30 min at 48°C and 5 min at 95°C. Reactions 
in which the enzyme or RNA were omitted were used as negative controls. Real time 
PCR was peliformed with an ABI prism 7000 sequence detection system and SYBR 
green I dye reagents. The specific primers were designed for human GAPDH and FasL 
using the Primer3 software program. The following primers were used in real time 
PCR: 
hGAPDH-RT-FPl: 5' TGGGCTACACTGAGCACCAG 3' 
hGAPDH-RT-RPl: 5' GGGTGTCGCTGTTGAAGTCA 3' 
hFasL-RT-FP: 5' GGCCTGTGTCTCCTTGTGAT 3' 
hFasL-RT-RP: 5' TGCCAGCTCCTTCTGTAGGT 3' 
hFasR-RT-FP: 5' TTG CTA GAT TAT CGT CCA AAA GTG TT 3' 
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hFasR-RT-RP: 5' AAC AGT CTT CCT CAA TTC CAA TCC 3' 
The ]parameter Ct (threshold cycle) was defined as the fraction cycle number at 
which the fhwrescence passed the threshold. The relative gene expression of FasL was 
analyzed using TMCt method (Livak and Schmittgen, 2001) by normalizing with 
GAPDH gene expression in all the experiments. 
Trypan blue dye exclusion 
To measure viability, cells were stained with trypan blue dye and then counted 
by light microscopy with a minimum of 100 total cells counted per slide, and scored as 
cells which were able to exclude the dye (alive) or unable to exclude the dye (dead). 
The results were expressed as the percentage of untreated cells (McClowskey et aI., 
1998). 
ImmunoprelCipitation and western blot analysis 
For immunoprecipitation (IP) of the Fas DISC, 20 x 106 lurkat T cells were 
untreated or treated with HNE 2.5, 5 or 10 [.tM for 3 h. Following treatment, cells were 
lysed with IP lysis buffer (PBS pH 7.4, 1 % NP-40, 200 ~M sodium orthovanadate, 0.1 
mg/ml PMSF, 10 ~g/ml aprotinin, 10 ~g/mlleupeptin, 4 ~g/ml benzamidine, 50 mM 
potassium fluoride, 1 mM p-glycerophosphate, 5 mM sodium pyrophosphate, 1 ~M 
okadaic acid) and the lysate (300 [.tg of protein/per sample) was incubated with 0.4 [.tg 
of anti-Fas (113-10) antibody with overnight rotation at 4°C. The following day, 20 [.tl of 
protein A/G plus agarose was added for 2 h rotation at 4°C and then 
immunoprecipitates were washed four times with IP lysis buffer, then separated on a 
10% SDS-PAGE and subjected to standard immunoblotting with an anti-FADD and 
anti-caspase-8 antibody. 
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Following treatment, cells were lysed and total cellular proteins (55-65 !lg of 
protein) were resolved on a 10 % SDS-PAGE and subjected to standard 
immunoblotting procedures. The primary antibodies used in this study were as 
follows: anti-FasL (C-178) 1:750; anti-FADD 1:1000; anti-caspase-8 1:100; anti-
FLIPy/8 1:750 and f3-Actin 1:1000. The appropriate secondary antibodies were used at 
1:2000 for FasL and FADD; 1:5000 for FLIPy/8 and f3-Actin and 1: 15,000 for caspase-
8. Proteins signals were visualized using the ECL system (Amersham Pharmacia 
Biotech, Piscataway, Nl), as directed by the manufacturer. The molecular sizes of the 
developed proteins were estimated by comparison with prestained protein markers 
(Invitrogen, Carlsbad, CA). 
Statistical analysis 
Data are expressed as means ± SD. Statistical analyses were performed using 
SPSS 11.5 (SPSS Ins., Chicago, IL) for Windows XP. Differences between the means 
of two groups were evaluated by a two-tailed t -test for independent samples. 
Differences between the means of three or four groups were evaluated by a single 
factor analysis of variance (ANOV A), and further assessed by Tukey tests. Differences 
were considered statistically significant for P < 0.05. 
RESULTS 
Effect of HNE and MDA on cell viability 
Our previous studies have shown that HNE leads to a significant loss in 
survival due to the induction of apoptotic death. Treatment of lurkat T cells with HNE 
significantly decreased survival to 32% (at 2.5 ).lM) and 22% (at 5 ).lM), respectively, 
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Fig. 8. Effects of HNE and MDA on cell viability. Cells were maintained in low serum 
medium (l % serum, over night) and then treated with 2.5 and 5 [!M HNE (A) or MDA 
(B) for 24 h. Cell survival was measured by Trypan blue exclusion assay. Data were 
normalized to the untreated control (which is set to 100%) and represented as mean ± SD 
of three separate experiments. *P<0.05 compared to UT . 
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of the untreated value (Fig. 8A). HNE also induced a dose dependent increase (2 to 2.5 
fold) in the DNA fragmentation in correspondence with the observed loss of T cell 
survival (data not shown). 
Since HNE had a significant effect on T cell survival, we further examined the 
effect of another lipid peroxidation product, MDA (2.5 and 5 ~M). In contrast to HNE, 
treatment of lurkat T cells with increasing concentrations of MDA had no effect on the 
T cell survival; the cell viabilities were 90 ± 0.05% and 85 ± 0.08% of untreated 
control at 2.5 and 5 ~M, respectively (Fig. 8B). 
Effects of HNE on Akt kinase 
The serine-threonine kinase (PKB/Akt) has been shown to be critical for T 
lymphocyte survival and inhibition of Akt leads to apoptotic T cell death. To further 
investigate the mechanism of HNE-induced apoptotic cell death, we studied the role of 
Akt kinase in the survival pathway. In untreated cells, Akt was found to be 
constitutively phosphorylated at Ser 473. The basal level of p-Akt in untreated cells 
was 28.61 ± 2.04 unit/mg protein. Cells were exposed to different concentrations of 
HNE 2.5, 5, and 10 ~M for 6 h. The resulting p-Akt concentrations were found to be 
20.99 ± 3.13, 3.17 ± 3.28, 1.45 ± 0.06 unit/mg protein, respectively, which were about 
37, 11 and 5% of the untreated values (Fig. 9A). The results of decreased phospho-Akt 
levels were further confirmed by western blot analysis. A dose-dependent 
dephosphorylation of phospho-Akt was observed in cells treated with HNE (2.5-10 
/-lM) at 3 h. Similarly, HNE effectively decreased Akt activation at 6 h. The most 
profound decrease in dephosphorylation of Akt was found at 10 /-lM HNE. There were 
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Fig. 9. HNE downregulates Akt activation. Sample preparation was as described in Fig. 
8A. (A) p-Akt concentration. Cell extracts were harvested at 6 h after HNE treatment. 
Data were normalized to protein concentration and p-Akt concentrations expressed as 
unit/mg protein. Data are represented as mean ± SD of three separate experiments. 
*P<O.Ol and **P<O.OOl compared to UT. (B) Western blotting. Total celllysates were 
collected for Western blot analysis as described in Materials and Methods. Akt and 
phospho-Akt were detected at 3 h (left panel) and 6 h (right panel) by immunoblotting 
using anti -Akt and phospho-Akt antibodies. Blots were stripped and reprobed with 
antibody to ~-actin to ensure equivalent loading. A representative gel out of three 
experiments is shown. 
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decreased phosphor- and total Akt expression at 6 h with HNE concentrations of 5 and 
10 11M (Fig. 9B). Thus, these results demonstrate that in a dose-dependent manner, 
HNE mediates the dephosphorylation of Akt in the early stage of apoptosis. 
Effects of HNE on PP2A activity 
PP2A is serine/threonine phosphatase and studies have shown that PP2A 
dephosphorylated and inactivated Akt in vitro (Van Kanegan et aI., 2005). To confirm 
the involvement of PP2A in the process of HNE-mediated Akt dephosphorylation, we 
next examined whether the overall catalytic activity of PP2A was upregulated after 
HNE treatment. Using a nonradioactive serine/threonine phosphatase assay kit with 
the phosphopeptide K-R-pT-I-R-R as a substrate, we measured the amount of released 
phosphate, which indicates PP2A catalytic activity. In untreated lurkat T cells, PP2A 
activity was determined by the phosphate release, which was 137 ± 42 pmol phosphate/ 
~g protein! 10 min. As shown in Fig. 10, at 30 min after HNE (2.5 and 5 11M) 
treatment, PP2A activities increased 160% (220 ± 43 pmol phosphate/ ~g protein! 10 
min) and 212% (290 ± 101 pmol phosphate/ ~g protein! 10 min), respectively, of the 
untreated value. Our results suggest that PP2A enzymatic activity is increased dose-
dependently in lurkat T cells treated with HNE. 
Effect of HNE on FasL expression 
Since FasL is a well established apoptotic stimulus for T lymphocytes, we 
examined FasL expression in the HNE treated lurkat T cells. Immunoblot analysis 
showed that treatment of cells with HNE (2.5 and 5 11M) for 6 h significantly increased 
FasL protein expression as compared to the untreated cells (Fig. lIA). On the other 
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Fig. 10. HNE increases PP2A activity. Sample preparation was as described in Fig. 8A. 
Cell extracts were harvested at 30 min after HNE treatment. PP2A activity was measured 
using PP2A immunoprecipitation assay kit as described in Materials and Methods. Data 
were normalized to protein concentration and PP2A activity expressed as pmol phosphate/ Ilg 
protein/lO min. Data are represented as mean ± SD of three separate experiments. ·P<0.05 
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Fig. 11. HNE enhances FasL expression. (A) Western Blot Analysis: Cells exposed to 
different concentrations of HNE (2.5,5 and 10 !-1M) and MDA (5 and 10 !-1M) for 6 h. Total 
celllysates were collected for Western blot analysis as described in Materials an d Methods. 
FasL was detected at 6 h by irnrnunoblot ting using an anti -FasL-specific antibody. Blots 
were stripped and reprobed with antibody to ~-actin to ensure equivalent loading. A 
representative gel out of three experiments is shown. (B) Real Time PCR: Total RNA was 
isolated from cells, untreated (UT) or treated with HNE (2.5 and 5 !-1M) at 1 h. (C) Real 
Time PCR: Total RNA was isolated from cells, untreated (UT) or treated with HNE (5 !-1M) 
at 1, 3 and 6 h. FasL mRNA levels were determined by real time PCR. Data are represented 
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(5 and 10 !lM) at 6 h showed no increase in FasL protein expression (Fig. lIA). To 
determine whether the enhancement in the FasL protein in response to HNE treatment 
was at the transcriptional level, we quantified the steady state FasL mRNA levels by 
real time PCR. Total RNA was isolated from T cells that were exposed to HNE (2.5 
and 5 !lM) in serum free medium for 15 min and then serum containing medium for 1 h 
and analyzed by real time PCR. The data showed that in correspondence with FasL 
protein expression, FasL rnRNA was significantly induced (approximately 2-fold) after 
1 h treatment with HNE (Fig. lIB). Total RNA was isolated from T cells exposed to 5 
!lM HNE for 1, 3 and 6 h, the time effect analyzed by real time PCR. The data showed 
that FasL rnRNA was induced (2 to 4 fold} after HNE treatment in a time-dependent 
manner (Fig. 11 C). 
Effects of HNE on Fas mediated DISC formation 
To further elucidate the effect of HNE, components of the FaslFasL apoptotic 
pathway were examined in HNE treated T cells. FasL binding to the Fas receptor (Fas) 
is known to induce the formation of DISC, involving the recruitment of FADD and 
subsequent recruitment and activation of caspase-8 (Peter and Krammer, 2003). 
Hence, the effect of HNE treatment on FADD recruitment to Fas was examined. A Fas 
antibody was used to immunoprecipitate the DISC from lysates (normalized for 
protein) of cells treated with HNE (2.5, 5 and 10 JlM). Irnmunoprecipitates were 
resolved using SDS-PAGE and examined by Western blot analysis using antibodies 
against FADD and Fas. Increased recruitment of FADD was seen in HNE treated cells 
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Fig. 12. HNE increases binding ofFADD to the DISC. Cells were incubated with HNE (2.5, 
5, and 10 IlM) for 3 h. Total celllysates were collected for irnrnunoprecipitation with Fas 
receptor antibody followed by irnrnunoblotting analysis with FADD or caspase -8 antibodies 
as described in Materials and Methods. Untreated cells (UT) were used as a negative control; 
blots were stripped and reprobed with Fas receptor antibody (pas B -10) to ensure equivalent 
loading. PHA (10 Ilglml) is a positive control. A repres entative gel out of three experiments 
is shown. 
Further analysis of the immunoprecipitates showed that the increase in FADD 
recruitment was accompanied by an increase in procaspase-8 recruitment into the DISC 
(Fig. 12). The 56 kDa procaspase-8 undergoes several processing steps to generate 
cleaved fragments ofp42-44 kDa, p28 kDa, p18 kDa and pl0-12 kDa in different cells 
undergoing apoptosis. HNE was found to significantly increase caspase-8 activation. 
This activation was documented by the presence of the p42 kDa cleavage product of 
caspase-8 in HNE treated celllysates (Fig. 13). 
Effect of HNE on c-FL1Ps expression, caspase-8 activity and DNA fragmentation 
To further elucidate the molecular mechanism of Fas-mediated apoptosis in 
response to HNE in T lymphocytes, we eX'8lIlined the effect of HNE on expression of 
c-FLIPs, since it has been demonstrated that c-FLIPs is a dominant negative inhibitor 
of caspase-8. Western analysis was performed on lurkat T cells showed that c-FLIPs 
levels decreased after HNE treatment (Fig. 14). Corresponding with the increase in 
FasL expression and decrease in c-FLIPs levels, HNE led to a significant dose-
dependent increase in caspase-8 activity (Fig. 15A). Moreover, pretreatment of lurkat 
cells with a caspase-8 specific inhibitor blocked the DNA fragmentation induced by 
HNE (Fig. 15B). This data suggests that HNE leads to caspase-8 dependent apoptotic 
death was caused by the up-regulation of FasL expression and down-regulation of c-
FLIPs levels (Figs. 11 and 14). 
Relevance of FasL expression to cell death induced by HNE 
To test the functional relevance of FasL expression in HNE-induced cell death, 
we examined whether the blocking of FaslFasL ligation would protect lurkat T cells 
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Fig. 13. HNE induces caspase -8 activation. Cells were exposed to different concentrations 
ofHNE (2.5, 5 and 10 [tM) for 6 h. Total celllysates were collected at 6 h for Western blot 
analysis as described in Materials and Methods. Untreated cells (UT) were used as a 
negative control. Pro and active caspase -8 was detected by inununoblotting using anti -
caspase-8 antibody. Blots were stripped and reprobed with antibody to ~-actin to ensure 
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Fig. 14. HNE downregulates c -FLIPs protein. Cells were exposed to different 
concentrations of HNE (2.5 ,5 and 10 ILM) for 3 h (left panel) and 6 h (right panel). Total 
celllysates were collected for Western blot analysis as described in Materials and Me thods. 
c-FLIPs was detected at 3 and 6 h by immunoblotting using anti -c-FLIP8/y antibody. Blots 
were stripped and reprobed with antibody to [3-actin to ensure equivalent loading. A 
representative gel out of three experiments is shown. 
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Fig. 15. HNE induces Caspase-8 dependent apoptosis. (A) Cell apoptosis was 
measured by caspase-8 activity assay. Cells were exposed to different concentrations 
of HNE (2.5, 5 and 10 ~M) and the total celllysates were collected at 6 h after HNE 
treatment for caspaspe-8 activity assay as described in Materials and Methods. Data 
were expressed as unit per mg of protein and represented as mean ± SD of six separate 
experiments. *P<0.05 compared to UT. (B) DNA fragmentation: Cells were 
maintained in low serum medium (l %, over night) and then pretreated with 100 ~M of 
Caspase-8 inhibitor (CI) for 1 h. After 1 h, cells were treated with increasing 
concentrations of HNE (2.5 and 5 ~M) for 8 h. Cell survival was then measured by 
DNA fragmentation using the Cell Death ELISA kit. Data were normalized to the 
untreated control (which is set to 1) and represented as mean ± SD of three separate 
experiments. In each experiment, duplicate wells are assayed separately for each 
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Fig. 16. Neutralization of FasL protects Jurkat T cells from apoptosis induced by HNE. 
Jurkat T cells were untreated (UT) or treated with HNE (2.5 and 5 ~M). In one group, 
NOK-2 antibody (50 Ilglrnl) or the isotype IgG 2a (50 ~glrnl) control was added 15 mi n 
after treating the cells with HNE, and then the cells were harvested a t 6 h to measure 
apoptosis. Cytoplasmic extracts were prepared and analyzed for DNA fragmentation by 
Cell Death ELISA kit as described in Materials and Methods. Data were normalized to 
the untreated control and represented as mean ± SD of three different experiments. *p< 
0.05 compared to UT, a p< 0.05 compared to HNE 5 ~M. 
which recognizes and neutralizes both membrane-bound and soluble forms of FasL in 
human by interfering with Fas/FasL ligation and inhibiting Fas signaling. Incubation 
of lurkat T cells with NOK-2 antibody after HNE (2.5 and 5 /-LM) treatment for 15 min 
attenuated apoptosis by approximately 8 and 24%, respectively. Treatment with the 
IgG2a isotype antibody (negative control) did not protect cells from undergoing 
apoptosis (Fig. 16). The results showed the association between HNE and Fas-
mediated apoptosis, suggesting HNE-induced apoptosis is partly mediated by FasL 
expression. 
DISCUSSION 
During the process of lipid peroxidation, several reactive low-molecular weight 
products are formed, including reactive aldehydes, e.g., 4-hydroxynonenal (HNE). 
HNE is one of the major aldehydic products of the peroxidation of membrane 0)-6 
poly-unsaturated fatty acids. It has been implicated as a causative agent in cytotoxic 
processes initiated by the exposure of cellular systems to oxidizing agents (Uchida, 
2003; Minotti et aI., 1991; Kalinich et aI., 1999). In comparison to free radicals, the 
aldehydes are relatively stable and can diffuse within or be released extra-cellularly and 
attack targets distant from the site of the original event. Significantly, HNE functions 
as an endogenous lipid mediator to induce a variety of cellular processes that represent 
a cellular response program under oxidative stress (Benedetti et aI., 1984). Clinically, 
HNE is highly likely to be causally involved in many of the pathophysiological effects 
associated with oxidative stress and immune dysfunction such as diabetes mellitus, 
alcoholism, and HIV and HCV infection (Clot et aI., 1994; Cambiaggi et aI., 1997; 
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Kajimoto et aI., 2002; Rigamonti et aI., 2003). In the context of immune dysfunction, 
HNE has been demonstrated to playa critical role in the down-regulation of cell 
proliferation and in the modulation of cell differentiation in T lymphocytes (Barrera et 
aI., 1991; Gioacchini et aI., 1999). CD4+ T cells are critical regulators of both the 
humoral and cell mediated immunity and their loss plays a significant role in immune 
dysfunction. Hence, the mechanisms underlying the effect of HNE on CD4+ T cell 
survival were examined. 
Our earlier results demonstrated that HNE (2.5 and 5 f,lM) induced dose-
dependant cell death as assessed by trypan blue exclusion and apoptosis as assessed by 
DNA fragmentation in lurkat cells (Chang, 2004). Others have also shown that HNE 
(20-50 f,lM) induced dose-dependent apoptosis in human lymphoma lurkat T cells. 
However, they showed that HNE at 20 f,lM reduced cell viability to approximately 60% 
of the untreated cells, whereas at lower concentrations (:s 10 f,lM) HNE had no effect 
(Brunner et aI., 2003; Liu et aI., 2000). However, the difference of the result is 
possibly through the source of HNE. Thus, our results along with others confirmed 
that HNE can cause cytotoxicity. Further our results showed that MDA, another lipid 
peroxidation product, had no effect on cell viability, suggesting that HNE is more toxic 
than MDA. Others have shown a similar pattern of toxicity in human fibroblasts when 
treated with HNE and MDA (Michiels and Remacle, 1991). HNE is highly reactive 
and has three reactive groups (i.e., an aldehyde, a double-bond, and a hydroxy group), 
which might possibly explain its higher toxicity through the initiation and propagation 
of a free radical chain reaction. 
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The serine-threonine kinase Akt (or PKB) is critical for survival and protection 
against apoptosis in various cells (Burgering and Coffer, 1995; Franke et aI., 1995). 
The balance between survival and apoptosis, specifically in T lymphocytes, is directly 
associated with immune function. Up-regulated Akt promotes cell survival by 
phosphorylating and thereby inhibiting a variety of downstream key proapoptotic 
targets such as GSK-3 (Cross et aI., 1995) and caspase-9 (Cardone et aI., 1998), and by 
activating transcriptional factors such as nuclear factor-KB (NFKB) and Forkhead 
(Kops and Burgering, 1999) in T lymphocytes. Survival factors are equally important 
in the regulation of the apoptotic process induced by oxidative stress. Studies 
demonstrated an early increase followed by a significant decrease in phosphorylation 
of Akt in methylpyridinium (MPP+)-induced apoptotic death in SH-SY5Y 
neuroblastoma cells (Halvorsen et aI., 2002). Others reported that excessive damage 
can increase dephosphorylation of Akt without a transient increase in Akt 
phosphorylation after focal cerebral ischemia in mice (Noshita et aI., 2001). Our 
results did not show that an early increase of Akt phosphorylation after HNE treatment 
could be due to HNE, a potent reactive oxidant which caused excessive damage in 
lurkat T cells. These findings support the PI3-kinase pathway as being predominantly 
anti-apoptotic, and together, suggest that prevention of Akt shutdown or increasing Akt 
activation may block apoptosis. 
Our results showed that p-Akt concentration in untreated lurkat was about 30 unit 
per mg protein and constitutively activated and that HNE downregulated Akt activation 
(Fig. 9). Others have shown that 20 IlM HNE-induced dephosphorylation of Akt at 
Ser473 in lurkat cells (Liu et aI., 2003). In comparison, we found that Akt inactivation 
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occurred at much lower concentrations of HNE (2.5-10 /lM). This finding is relevant to 
pathophysiological conditions, since HNE at these concentrations was found to alter cell 
signaling, and to cause DNA damage, cytotoxicity, and apoptosis. 
Similar results from other oxidative stimuli such as H202 on Akt activity were 
observed. We found that when lurkat T cells were exposed to H20 2 (100-500 /lM), there 
was a downregulation of Akt activation as assessed by Western blot analysis (data not 
shown). Others demonstrated that phospho-Akt expression was decreased in neonatal rat 
ventricular myocytes exposed to H20 2 for 15 min (Jamnicki-Abegg et aI., 2005). In 
addition, decreases in both activating phosphorylation of Akt and total Akt in H20 2-
induced apoptotic death were observed in cardiac H9c2 cells (Murata et aI., 2003). 
Treatment of human embryonic kidney cells with H202 decreased Akt activities and 
increased apoptosis as indexed by cell shrinkage and DNA fragmentation (Shaw et aI., 
1998). Furthermore, treatment with a PI3K1 Akt inhibitor (L Y294002) resulted in Akt 
inactivation and apoptosis in mouse fibroblast and human leukemia cell lines (Uriarte et 
aI.,2005). Thus, results from our findings and from others clearly demonstrate that HNE 
and other oxidative stimuli induced apoptotic cell death in T lymphocytes, and were 
closely related to the downregulation of Akt activity. 
In mammalian cells, protein phosphorylation and dephosphorylation involved in 
distinct survival signaling pathways plays an important role in apoptosis. PP2A is the 
most abundant serine/threonine-specific phosphatase and plays a role in multiple cellular 
functions such as cell division, signal transduction, and development (Chen et aI., 1992). 
PP2A plays a critical role in Akt inactivation, for it dephosphorylates two 
phosphorylation sites (Ser473 and Thr308) of Akt and forms a complex with Akt (Ivaska 
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et aI, 2002; Resjo et aI., 2002). In this study, we showed that HNE increased PP2A 
catalytic activity (Fig. 10), and concomitantly downregulating Akt (Fig. 9). Others have 
also demonstrated that HNE increased PP2A activity, and pretreatment of Jurkat T cells 
with a PP2A inhibitor, okadaic acid, prevented this increase (Liu et aI., 2003). H202 has 
been shown to increase apoptosis and the dephosphorylation of Akt by increasing 
interaction between PP2A and Akt in H9c2 cells. But, no direct increases of PP2A 
activity were observed (Murata et aI., 2003). The involvement of PP2A is not 
completely understood. Recent studies have shown that TNF-induced endothelial 
apoptosis involves the activation of Bad via PP2A-dependent inhibition of MEK 
phosphorylation (Grethe and Pron-Ares, 2006). Together, these studies suggest that 
phosphorylation and dephosphorylation plays an important role in regulating HNE 
mediated cellular processes such as survival and apoptosis by Akt kinases and PP2A. 
FasL expression plays a major role in the AICD of activated mature T cells and T 
cell hybridomas (Martinez-Lorenzo et aI., 1998). Exposure of CD4+ T cells (Jurkat) to 
HNE led to an up-regulation in FasL mRNA and protein (Fig. 11). Apoptosis induced by 
HNE was blocked by incubation with FasL neutralizing antibody, demonstrating the 
functional relevance of FasL expression in T cells exposed to lipid peroxides. Although 
neutralization of FasL significantly protected T cells from undergoing apoptosis, the 
NOK-2 antibody did not completely abrogate DNA fragmentation (Fig. 12). This finding 
suggests the possible involvement of both Fas-dependent and Fas-independent pathways 
leading to T cell death under these conditions. 
Activation of Fas by FasL leads to its trimerization and recruitment of the 
adaptor molecule FADD and procaspase 8, forming DISC (Chinnaiyan. et aI., 1995; 
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Schraven and Peter, 1995; Uriarte et aI., 2005). Our data show that exposure ofT cells 
to HNE induces FasL expression leading to Fas-FasL-dependent clustering of Fas and 
formation of DISC involving recruitment of FADD and procaspase-8 (Fig. 13). Also, 
the presence of cleaved caspase-8 together with FADD and procaspase-8 in the DISC 
assembly (Fig. 14) showed that caspase-8 is activated at the DISC (Medema et aI., 
1997). Moreover, HNE treatment enhanced the recruitment ofFADD and procaspase-
8 in a dose-dependent manner, suggesting that the enhancement in DISC formation 
corresponds with the levels of HNE or degree of lipid peroxidation experienced by the 
T lymphocytes. Apoptosis of activated T cells mediated by Fas has been shown to be 
regulated by c-FLIP expression (Krueger et aI., 2001). There are two isoforms of c-
FLIP, c-FLIPs and c-FLIPL, both of which can be recruited to the DISC (Krueger et 
aI., 2001a; Tibbetts et aI., 2003). Although the role of c-FLIPL is controversial, in T 
cells c-FLIPs was shown to be antiapoptotic and to confer resistance to Fas-mediated 
apoptosis by blocking proteolytic activation of caspase-8 at the DISC (Krueger et 
aI., 2001, 2001a; Irmler et aI., 1997). Our study showed that HNE treatment 
downregulates c-FLIPs expression, implicating c-FLIPs as an important regulator of 
HNE-mediated apoptosis in T cells (Fig. 15). 
In HNE treated cells the resultant increase in FasL expression, DISC assembly 
and caspase-8 activation was accompanied by DNA fragmentation. Others have shown 
that HNE induces a cellular redox status related to the activation of caspases, including 
caspase-8, -9 and -3 and induction of apoptotic cell death in Jurkat T lymphocytes (Liu 
et aI., 2000). Our findings further extend these observations and identify the formation 
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of DISC leading to increased caspase-8 activation as the critical initiator of apoptotic 
death induced in T lymphocytes by HNE. 
In conclusion, we showed that HNE induced significant loss of survival due to 
enhanced FasL expression, in turn, leading to the induction of the DISC and a 
corresponding decrease in c-FLIPs protein and caspase-8 activation. These data 
identify a pathogenic molecular mechanism(s) induced by HNE in CD4+ T cells and is 
consistent with a potential role of lipid peroxidation-derived products in programmed 
cell death. Importantly, this work has begun to elucidate the potential role of lipid 
peroxidation products, in particular HNE, in the pathogenesis of immunosuppressive 
disorders involving CD4+ T cell depletion such as HIV and HCV infection, and this 
work can lead to the development of much needed anti-oxidant therapies. 
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CHPATERIII 
ROLE OF GSH AND PTCA PROTECTION IN HNE-INDUCED 
CYTOTOXICITY 
INTRODUCTION 
The studies on HNE toxicity in human CD4+ T lymphocytes described in this 
chapter were design to test the protective role of PTCA in HNE-induced T cell death. 
The effect of PTCA on HNE-induced cytotoxicity was studied and the role of GSH and 
Akt kinase and Fas-mediated death signaling were further evaluated. Cytotoxicity was 
assessed as described in Chapter II. To evaluate the role of GSH in toxicity, the effects 
of HNE on GSH concentrations and the ability of GSH precursor PTCA to protect 
against HNE toxicity were determined. To evaluate the role of Akt kinase in toxicity, 
the effects of PTCA on HNE-induced Akt downregulation and PP2A activation were 
examined. To evaluate the protection of Fas-mediated death signaling, the effects of 
PTCA on FasL and c-FLIPs expression of HNE toxicity were examined. Finally, to 
evaluate the possibile sensitizating effect of GSH depletion, the effects of BSO, a GSH 
biosynthesis inhibitor, on MDA toxicity were examined. 
MATERIALS AND METHODS 
Cell culture 
Jurkat T cells were obtained and prepared as described in Chapter II. 
52 
Chemicals 
2(RS)-n-propylthiazolidine-4(R)-carboxylic acids was synthesized and kindly 
provided by Dr. Herbert T. Nagasawa (VA Medical Center, Minneapolis, MN). BSO 
and MPA were purchased from Sigma Chemical Co. (St. Louis, MO). 
Analyses of GSH 
Cell pellets were dispersed with 0.25 ml of 4% MPA and centrifuged at 10,000 
x g for 2 min. The supernatants were collected for GSH analysis using an HPLC 
method with dual electrochemical detection (HPLC-DEC; Richie et aI., 1987; Chen et 
aI., 1990). In brief, 20 f!l samples were injected onto a 250 x 4.6 mm, 5 f!m, C-18 
column (Val-V-Pak HP, fully endcapped ODS, Chrom Tech Inc., Apple Valley, MN), 
eluted isocratically with a mobile phase consisting of 0.1 M monochloroacetic acid, 2 
mM heptane sulfonic acid, and 2% acetonitrile at pH 2.8, and delivered at a flow rate 
of 1 ml/min. The compounds were detected in the eluant with a Bioanalytical Systems 
model LC4B dual electrochemical detector using two Au-Hg electrodes in series with 
potentials of -1.00 V and +0.15 V for the upstream and downstream electrodes, 
respectively. Current (nA) was measured at the downstream electrode. Analytes were 
quantified from peak area measurements using authentic external standards. 
Akt [pS473] ELISA assay 
lurkat T cells were pretreated with PTCA at 250 f!M for 1 h before the addition 
ofHNE at 2.5 or 5 )!M. Samples were collected at 6 h and lysed for determination of 
the phosphorylated Akt levels using an Akt [pS473] kit. Method details were 
described in Chapter II. 
DNA fragmentation ELISA assay 
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lurkat T cells were pretreated with PTCA at 250 J..lM for 1 h before the addition 
ofHNE at 2.5 or 5 J..lM. Method details were described in Chapter II. 
PP2A enzymatic activity assay 
lurkat T cells were pretreated with PTCA at 250 J..lM for 1 h before the addition 
ofHNE at 2.5 or 5 J..lM. PP2A enzymatic activity was assessed following PP2A 
immunoprecipitation using a malachite green based phosphatase assay (PP2A 
Immunoprecipitation Phosphatase Assay Kit). Method details were described in 
Chapter II. 
Western blot analysis 
15 x 106 lurkat T cells were pretreated with PTCA at 250 J..lM for 1 h before the 
addition of HNE at 2.5, 5, or 10 !AM for 3 and/or 6 h. Following treatment, cells were 
lysed by immunoprecipitation lysis buffer and total cellular proteins (65 !Ag of protein) 
were resolved on a 10 % SDS-PAGE and subjected to standard immunoblotting 
procedures. The primary antibodies used in this study were as follows: anti-phospho-
Akt 1:500; anti-Akt 1:500; anti-Fas-L (C-178) 1:750; anti-FLIPy/8 1:750 and ~-Actin 
1: 1000. The appropriate secondary antibodies were used at 1 :2000 for phospho-Akt, 
total Akt, and FasL; 1 :5,000 for FLIPy/8 and ~-Actin. Proteins signals were visualized 
using the ECL system (Amersham Pharmacia Biotech, Piscataway, Nl), as directed by 
the manufacturer. The molecular sizes of the developed proteins were estimated by 
comparison with prestained protein markers (Invitrogen, Carlsbad, CA). 
RNA isolation and real time peR analysis 
Method details were described in Chapter II. 
Trypan blue dye exclusion 
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Method details were described in Chapter II. 
Statistical analysis 
Analyses were performed as described in Chapter II. 
RESULTS 
PTCA protects against HNE-induced cytotoxicity 
Our previous studies have shown HNE-induced dose-dependent cytotoxicity 
and apoptotic cell death in lurkat cells. In this study, lurkat T cells pretreated with 
PTCA, a GSH precursor, cell viabilities were increased by about 80% from the 
untreated value as compared to 20-25% survival with HNE alone (Fig. 17 A). 
Pretreatment of lurkat T cells with PTCA, DNA fragmentation, an index of apoptosis, 
were decreased to about 1.8-fold of the untreated value as compared to 2.5-fold of cells 
treated with HNE alone (Fig. 17B). 
PTCA attenuates HNE-induced decreases in GSH concentration 
Previously, we found that HNE produced a time-and dose-dependent depletion 
of intracellular GSH. The basal GSH concentration was 37.1 ± 8.6 nmol/mg protein. 
GSH concentration was 70% depleted by 15 min after HNE treatment and reached a 
maximal depletion of 90% at 1 h, and remained low through out 3 h (data not shown). 
At the lowest HNE concentration (2.5 ).!M), GSH was 80% depleted at 3 h. At higher 
HNE concentrations (5-20 ).!M), GSH was completely depleted. Pretreatment of lurkat 
T cells with PTCA markedly attenuated HNE-induced decreases in intracellular GSH 
concentration. GSH concentrations in cells pretreated with PTCA were increased to 





























PTCA H 2.S H 2.S+PTCA HS H S+PTCA 
Fig. 17. PTCA protects against HNE-induced cytotoxicity. lurkat T cells were 
pretreated with PTCA at 250 flM for 1 h before the addition ofHNE at 2.5 or 5 flM. 
Cells were untreated (UT), or treated with PTCA (250 flM) or HNE (2.5 or 5 flM), or 
PTCA plus HNE. (A) Trypan blue exclusion assay. Cell survival was quantified at 24 h. 
Data were normalized to the untreated control (which is set to 100%) and represented as 
the mean ± SD of five separate experiments. (B) DNA fragmentation assay. 
Cytoplasmic extracts were prepared and analyzed at 6 h for DNA fragmentation by Cell 
Death ELISA kit as described in Materials and Methods. Data were normalized to the 
untreated control (which is set to 1) and represented as mean ± SD of four separate 
experiments. In each experiment, duplicate wells are assayed separately for each 
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Fig. 18. PTCA attenuates HNE -induced GSH depletion and cytotoxicity. (A) GSH 
concentration. Sample preparation was as described in Fig. 17 and cell extracts were 
collected at 3 h. "nd" indicated none detected. (B) Relationship between GSH 
concentration and lurkat T cell death. GSH concentration determined at 3 h and cell 
viability at 24 h after HNE treatment. Cytotoxicity is expressed as inverse of cell 
viability. Each point presented value obtained with a given treatment. Plot included data 
from all experiments in cells in which both cytotoxicity and GSH were determined. 
*P<O.OS compared to UT, a,b P<O.OS compared to HNE 2.S and S fA, M, respectively. 
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From the above results, we plotted the cytotoxicity vs. GSH concentration. As 
shown in Fig. 18B, there was a close correlation (R2=0.9908) between GSH 
concentration and cytotoxicity. And it appears that when GSH was depleted to about 
80-90% of controls (threshold level), the cytotoxicity was ensued. 
Effects of MDA and BSO on intracellular GSH concentrations and cell viability 
The effect of MDA (2.5-10 f.lM), another lipid peroxidation product, on 
intracellular GSH concentrations was also investigated. As shown in Fig. 19A, the 
basal GSH concentrations were 30.6 and 41.9 nmol/mg protein, respectively, at 3 and 6 
h. GSH concentrations were 32.7,34.5, and 33.2 nmol/mg protein, respectively, 3 h 
after cells exposed to MDA at 2.5, 5 and 10 f.lM. The effects of various doses of MDA 
(2.5-10 f.lM) on intracellular GSH concentrations at 6 h were 41. 7, 40.4 and 41.6 
nmol/mg protein, respectively. In contrast to the results of HNE, MDA had no effect 
on GSH concentration in Jurkat T cells. 
BSQ, an inhibitor of GSH biosynthesis, has been demonstrated to decrease 
GSH concentrations in many cell lines. As shown in Fig. 19B, Jurkat T cells treated 
with BSQ for 24 h, GSH concentrations decreased to 0.511 ± 0.074 nmol/mg protein 
(2.5 mM) and 0.02 ± 0.031 nmol/mg protein (5 mM), respectively. Effects of BSQ on 
T cell survival was further examined in Jurkat T cells treated with BSQ. Cell 
viabilities in the BSQ treated group at 2.5 and 5 mM were 106% and 74% of controls, 
respectively (Fig. 19C). The results suggest that BSQ (at 2.5 mM) had no significant 
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Fig. 19. Effects of MDA and BSO on intracellular GSH concentration and cytotoxicity. 
(A) GSH concentrations. Jurkat T cells were untreated (UT) or treated with MDA (2.5, 
5 and 10 ~M). Cells were harvested at 3 and 6 h after MDA treatment. (B) GSH 
concentration. Jurkat T cells were untreated (UT) or treated with BSO (2.5 and 5 m M). 
Cells were harvested at 24 h after BSO treatment. Data were normalized to protein 
concentration (nmol/mg) and represented as mean ± SD of three separate experiments. 
(C) Trypan blue exclusion assay. Sample preparation was as described in Fig. 19B. 
Data were normalized to the untreated control (which is set to 100%) and represented as 
































PTCA protects against HNE-induced decrease of Akt activation 
The serine/threonine kinase (AktlPKB) has been shown to be critical for T 
lymphocyte survival and inhibition of Akt leads to apoptotic T cell death. Our 
previous results showed that HNE induced a time-and dose-dependent decreases of p-
Akt. In untreated Jukat T cells, Akt is constitutively phosphorylated at Ser-473, and 
the basal concentration of p-Akt was 28.6 ± 1.0 unit/mg. p-Akt concentrations were 
decreased to 73% and 11 % of the untreated values, respectively, on HNE at 2.5 and 5 
).lM. In Jurkat T cells pretreated with PTCA, p-Akt concentrations were increased to 
about 115% and 70%, respectively, of the untreated value. PTCA alone had no effect 
on the p-Akt activation (Fig. 20A). 
We further confirmed the increased p-Akt levels by immunoblot analysis on 
phospho-Akt and Akt protein expression on cells treated with HNE (2.5 and 5 f!M). As 
shown in Fig. 20B, treatment of Jurkat T cells with HNE decreased phospho-Akt 
protein expression and PTCA pretreatment protected against HNE-induced 
downregulation of phospho-Akt protein at 6 h. We reprobed the same membrane with 
anti-Akt primary antibody. The results demonstrated a similar pattern as phospho-Akt 
protein expression, indicating that not only phospho-Akt was inactivated but Akt 
kinase was depleted 6 h after HNE treatment. 
In addition, we plotted GSH concentration vs. p-Akt levels, there was a close 
correlation (R2=0.9668) between the GSH concentration and cell survival as indexed 
by p-Akt levels. Thus, the threshold phenomenon in HNE-induced cytotoxicity vs. 
GSH (Fig. 18B) shown above was also observed in GSH vs. survival (Fig. 20C). All 
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Fig. 20. PTCA protects against HNE -induced downregulation of Akt kinase expression. 
Sample preparation was as described in Fig. 18. (A) p-Akt concentration s. Cell extracts 
were harvested at 6 h after HNE treatment. Data were normalized to protein 
concentration and p-Akt concentration expressed as unitlmg protein. Data are 
represented as mean ± SD of three separate experiments. *P<O.OS compared to UT, a.b 
P<O.OS compared to HNE 2.S and S [l M, respectively. (B) Western blotting. Total cell 
lysates were collected at 6 h for Western blot analysis as described in Materials and 
Methods. Akt and phospho-Akt were detected at 6 h by immunoblot ting using an anti-
Akt and phospho-Akt antibodies. Blots were stripped and reprobed with antibody to ~­
actin to ensure equivalent loading. A representative gel out of three experiments is 
shown. (C) Relationship between GSH concentration and p-Akt concentrations in Iurkat 
T cells. GSH concentration determined at 3 hand p-Akt concentrations at 6 h after HNE 
treatment. Each point presented value obtained with a given treatment. Plot includes 
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together, these results suggested that PTCA protects against HNE-induced cytotoxicity 
possibly through upregulation of p-Akt. 
PTCA decreases HNE-induced PP2A activation 
PP2A is serine/threonine phosphatase and studies have shown that PP2A 
dephosphorylated and inactivated Akt in vitro (Van Kanegan et aI., 2005). To confirm 
the involvement of PP2A in the process of HNE-mediated Akt dephosphorylation, we 
examined whether the overall catalytic activity of PP2A was upregulated after HNE 
treatement. Using a nonradioactive serine/threonine phosphatase assay kit with the 
phosphopeptide K-R-pT-I-R-R as a substrate, we measured the amount of phosphate 
released, which indicates PP2A catalytic activity. As shown in Fig. 21A, cells exposed 
to HNE (2.5 and 5 [lM) after 30 min, PP2A activities were increased to 150% (202 ± 
41 pmol phosphate / /-lg proteinllO min) and 210% (288 ± 28 pmol phosphate / /-lg 
proteinllO min), respectively, of the untreated value. Pretreatment of lurkat cells with 
PTCA for 1 h before the addition of HNE (2.5 and 5 [lM), PP2A activities were 
decreased to 121 % (166 ± 40 pmol phosphate / /-lg protein/ 10 min) and 104% (142 ± 
49 pmol phosphate / /-lg protein/ 10 min), respectively, of the untreated value. PTCA 
alone had no effect on the PP2A activity. The results on PP2A activity were further 
confirmed by protein expression. As shown in Fig. 21B, treatment of lurkat T cells 
with HNE (2.5, 5 and 10 [lM) increased PP2A expression on both A subunit (62KDa) 
and C subunit (36KDa). Pretreatment of lurkat T cells with PTCA inhibit HNE-
induced activation of PP2A protein. Together, the results demonstrated that HNE 
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Fig. 21. PTCA inhibits HNE-induced PP2A activation. Sample preparation was as 
described in Fig. 17. (A) Cell extracts were harvested at 30 min after HNE treatment. 
PP2A activity was measured using PP2A immunoprecipitation assay kit as described in 
Materials and Methods. Data were normalized to protein concentration and PP2A 
activity expressed as pmol phosphate/I-lg protein/1 0 min. Data are represented as mean ± 
SD of three separate experiments. *P<0.05 compared to UT, a P<0.06 compared to HNE 5 
/!M. (B) Western blotting. Total celllysates were collected at 6 h for Western blot 
analysis as described in Materials and Methods. PP2Ac and PP2Aa were detected at 6 h 
by immunoblotting using an anti -PP2Ac and PP2Aa antibodies. Blots were stripped and 
reprobed with antibody to ~-actin to ensure equivalent loading. A representative gel out 


























immunoblot analysis. Also, pretreatment of lurkat T cells with PTCA blocked these 
effects. 
Effects of PTCA on HNE-induced FasL and c-FL1Ps expression 
FaslFasL-mediated apoptosis is a common mechanism for T cell death in many 
situations including activation-induced cell death (AICD), as well as Akt inhibition-
induced death (Uriarte et al., 2005). In our previous studies, we demonstrated that 
HNE-induced apoptosis is through FasL and FADD. Thus, we further examined the 
effects of PTCA on FasL expression. As shown in Fig. 22A, treatment of lurkat T 
cells with HNE increased FasL expression at higher concentration and PTCA 
pretreatment circumvented HNE-dependeRt upregulation of FasL protein at 6 h. To 
further investigate if the effect of the above events were at the transcriptional level, we 
analyzed FasL mRNA levels by real time-PCR. HNE at 2.5 )..LM had no effect on FasL 
mRNA. Similar to FasL expression, pretreatment of lurkat cells with PTCA markedly 
reduced the FasL mRNA to about four-fold compared to HNE (5 )..LM) alone (Fig. 
22B). Thus, PTCA was shown to down-regulate FasL gene expression induced by 
HNE. 
c-FLIPs is an anti-apoptotic protein, and has been shown to inhibit Fas-
mediated apoptosis (Krueger et aI., 2001). Since PTCA protects against apoptosis and 
down-regulates FasL expression induced by HNE, we further examined the effects of 
PTCA on c-FLIPs expression. Western analysis was performed on lurkat T cells 
which showed that c-FLIPs levels were decreased after HNE treatment (Fig. 23). 
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Fig. 22. PTCA protects against HNE -induced upregulation of FasL. Sample preparation was 
as described in Fig. 17. (A) Western blotting. Total celllysates were collected at 6 h for 
Western blot analysis as described in Materials and Methods. FasL was detected at 6 h by 
immunoblotting using an anti -FasL-specific antibody. Blots were stripped and reprobed with 
antibody to ~-actin to ensure equivalent loading. A representative gel out of three 
experiments is shown. (B) Real time -PCR. Total RNA was isolat ed from cells, untreated 
(UT) or treated witb HNE (2.5 and 5 [!M) at 6 h. FasL mRNA levels were determined by 
real time PCR. Data are represented as mean ± S D of five separate experiments. ·P<O.05 
compared to UT, a P<O.05 compared to HNE 5 [! M. 
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Fig. 23. Effects ofBSO on Akt, p-Akt, FasL and c-FLIPs protein expression. Sample 
preparation was as described in Fig. 19B. (A) Western blotting. Total celllysates were 
collected at 24 and 48 h for Western blot analysis as described in Materials and Methods. 
Akt, p-Akt, FasL and c-FLIPs were detected at 24 h (left panel) or 48 h (right panel) by 
immunoblotting using anti-Akt, p-Akt, FasL and c-FLIPy/1> antibodies. (B) Western blotting. 
lurkat T cells were pretreated with BSO at 5 mM for 24 h before the addition of MDA at 10 
11M at 2 or 24 h. Cells were untreated (UT), or treated with BSO (5 mM) or MDA (lO 11M), 
or BSO plus MDA. Blots were stripped and reprobed with antibody to ~-actin to ensure 
equivalent loading (data not shown). A representative gel out of two experiments i s shown. 
(C) Trypan blue exclusion assay. Sample preparation was described in Fig. 19B. Data were 
normalized to the untreated control (which is set to 100%) and represented as the mean ± S D 
of five separate experiments. ' P<O.OOl compared to UT, a,bp<O.OI compared to BSO and 
MDA, respectively, 
increases in c-FLIPs levels. Thus, PTCA was shown to circumvent c-FLIPs 
downregulation induced by HNE. 
Correlation of GSH content with lipid peroxidation 
We have observed that BSO decreases GSH concentrations without affecting 
cell viability (Fig. 19). We further examined the effect of BSO on Akt, phospho-Akt, 
FasL and c-FLIPs protein expression. As shown in Fig. 24A, treatment of Jurkat T 
cells with BSO (2.5 and 5 mM) for 24 and 48 h, phospho-Akt was not changed at 24 h, 
but was decreased slightly at 48 h. In correspondence with BSO treatment on survival 
(Fig. 19C), there was no change on total Akt protein expression both at 24 and 48 h. 
The results suggest that inhibition of GSH-concentration may slightly induce Akt 
inactivation through dephosphorylation, but total Akt protein expression was not 
affected. Further, we found that BSO has no effect on FasL and c-FLIPs protein 
expression. 
Since HNE significantly decreased T cell survival and GSH concentration, we 
then examined the effect of another lipid peroxidation product, MDA, on T cell 
survival. Jurkat T cells treated with MDA (10 IlM) or BSO (5 mM) alone had no effect 
on cell viability (Fig. 24C). However, pretreatment of Jurkat cells with BSO before the 
addition of MDA (10 IlM) significantly decreased Akt and phospho-Akt expression 
(Fig. 24B) as well as produced a profound cell death (33% of controls) (Fig. 24C). 
These results demonstrated that GSH depletion caused by BSO sensitizes Jurkat T cells 
to the secondary hit caused by lipid peroxides and induces the potentiation of 
cytotoxicity, suggesting that GSH may play an important role in T cell viability. 
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Fig. 24. Effects of BSO on Akt, p-Akt, FasL and c-FLIPs protein expression. Sample 
preparation was as described in Fig. 20B. (A) Western blotting. Total celllysates 
were collected at 24 and 48 h for Western blot analysis as described in Materials and 
Methods. Akt, p-Akt, FasL and c-FLIPs were detected at 24 h (left panel) or 48 h 
(right panel) by immunoblotting using anti-Akt, p-Akt, FasL and c-FLIPy/o antibodies. 
(B) Western blotting. Jurkat T cells were pretreated with BSO at 5 mM for 24 h before 
the addition of MDA at 10 JlM at 2 or 24 h. Cells were untreated (UT), or treated with 
BSO (5 mM) or MDA (10 JlM), or BSO plus MDA. Blots were stripped and reprobed 
with antibody to ~-actin to ensure equivalent loading (data not shown). A 
representative gel out of two experiments is shown. (C) Trypan blue exclusion assay. 
Sample preparation was as described in Fig. 8B. Data were normalized to the untreated 
control (which is set to 100%) and represented as the mean ± SD of five separate 
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DISCUSSION 
Clinical studies have demonstrated that oxidative stress is an important 
pathological factor in several immunosuppressive diseases. A critical factor in 
immunosuppression is the loss of CD4+ T lymphocytes, which are the central 
regulators of both cell-mediated and humoral immune responses (Cook, 1999). In 
chapter II, we demonstrated that HNE induces Fas-mediated apoptosis and cytotoxicity 
in lurkat T cells. However, the underlying mechanism is not clear. Numerous studies 
suggest that intracellular events such as GSH depletion, caspase activation, DNA 
fragmentation, chromatin condensation, and cytochrome c release may be involved in 
the apoptotic pathway initiated by HNE (Uchida, 2003). The present study focuses on 
the role of GSH in HNE-induced toxicity as well as the possible cytoprotection by a 
GSH precursor, namely PTCA. 
Role of GSH in Cytotoxicity 
GSH is the most abundant antioxidant in the body. It plays an important role in 
the circumvention of cellular oxidative stress and in the maintenance of intracellular 
thiol redox status (Khanna et aI., 1998). Clinically, a decreased level of cellular GSH 
has been observed in association with a number of pathological conditions including 
diabetes, liver cirrhosis, drug poisoning, age-related disorders, and AIDS (Sen, 1997). 
In addition, GSH content in many cultured cell lines including lurkat T lymphocytes 
plays an important role in cell cycle, function, proliferation, and survival (Soderdahl et 
aI.,2003). Previously, we found that HNE decreases intracellular GSH in a dose- and 
time-dependent manner, and their correlates with the induction of DNA fragmentation. 
The HNE-induced decreases in intracellular GSH concentration could be due to the 
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utilization of GSH by HNE to form HNE-GSH adducts. In the present study, 
restoration of intracellular GSH levels achieved by PTCA, a GSH precursor, on cell 
survival and GSH enhancement was observed. PTCA functions similar to NAC by 
supplying Cys for GSH synthesis in a prodrug form, but PTCA releases Cys 
spontaneously and is independent of enzymatic hydrolysis (Nagasawa et aI., 1984). 
Our work is the first demonstration that PTCA attenuates HNE-induced cytotoxicity is 
possibly due to GSH restoration in Jurkat T lymphocytes. PTCA has been shown to 
attenuate AP AP- and PAP-induced hepatic GSH depletion and hepatotoxicity in mice 
(Srinivasan et aI., 2001) and hamsters (Fu et aI., 2004). Studies have shown that PTCA 
restored the AP AP-induced depletion of total hepatic and mitochondria GSH in Swiss-
Webster mice (Nagasawa et aI., 1984). Other antioxidant such as NAC was shown to 
block HNE-induced DNA fragmentation in Jurkat cells (Liu et aI., 2000). Others have 
also shown that pretreatment of Jurkat cells with anethole dithiolethione (10-50 mM, 
18 h) attenuated HNE and H20 2-induced cytotoxicity and GSH depletion (Khanna et 
aI., 1998). In HIV -infected patients, NAC administration resulted in a relative increase 
in the CD4/CD8 ratio (Look et aI., 1998) and a slower decline of the CD4+ T cell count 
(Akerlund et aI., 1996). However, there is controversy over changing GSH 
concentrations. L-2-0xothiazolidine 4-carboxylate, another Cys precursor, 
significantly increased serum GSH concentrations in HIV -infected patients (Raju et aI., 
1994). Together, our results along with others suggest that GSH plays an important 
role in HNE-induced cytotoxicity. Further, PTCA protects against HNE-induced 
cytotoxicity, possibly mediated by increasing intracellular GSH concentrations. 
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Unlike the profound effect ofHNE on T cell GSH depletion, our results showed 
that MDA (2.5-10 !lM), another lipid peroxidation product, had no effect on GSH 
levels either at 3 or 6 h, suggesting that GSH is attacked by HNE to a greater effect 
from MDA. BSO, an inhibitor of GSH biosynthesis, has been shown to disturb the 
redox balance and enhance the vulnerability ofPC12 cells to oxidative stress (Seyfried 
et aI, 1999). In contrast to the effect of PTCA on GSH enhancement, pretreatment with 
BSO for 24 h, significantly depleted GSH without affecting T cell viability (Fig. 19). 
Similar studies were performed with diethyl maleate (DEM), a GSH scavenger. It 
depletes GSH within 1 h in hepatocytes and produces no appreciable change in cell 
viability (Chen et al., 2005). Additional studies have focused on the sensitization of 
cells to oxidative stress. Spitz et al. (1991), demonstrated that pretreatment of Chinese 
hamster fibrcblasts and clonogenic cells with BSO potentiates HNE-induced 
cytotoxicity by causing about 90% depletion of GSH, which corresponds with a loss in 
the cell ability to metabolize HNE. Others also have demonstrated a significant 
increase of cytotoxicity in hepatocytes with a combination ofBSO and S-nitroso-N-
acetyl-D,L-penicillamine, a nitric oxide donor. This combined regimen led to an 
increase in LDH release and oxidative stress, disruption of mitochondrial membrane 
potential, and a decrease in ATP content (Chen et al., 2005). These results agree with 
our finding ~hat GSH depletion sensitized T cells to the effect ofMDA (Fig. 24C). 
A pl<Dt of cell viability vs. GSH concentration under the different experimental 
conditions olfthis study (Fig. 18B) demonstrates a GSH threshold phenomenon in 
HNE-induced cytotoxicity in CD4+ T lymphocytes, which was also observed in in vivo 
studies (Fu ¢t al., 2004). There was no decrease in T cell viability at GSH 
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concentratioQ.s approximately above 20% of the untreated controls. Thus, intracellular 
GSH plays aJIl important role in cell viability; at GSH depletion of 80-90%, which most 
likely involv¢s depletion of mitochondria GSH, results in cytotoxicity. 
Role of GSa in the survival factor, Akt 
The serine-threonine kinase Akt (or PKB) is critical for survival and protection 
against apop~osis in various cells (Burgering and Coffer, 1995; Franke et aI., 1995). 
Specifically ~n T lymphocytes, the balance between survival and apoptosis is directly 
associated with immune function. Up-regulated Akt promotes cell survival by 
phosphorylat~ng a variety of downstream key proapoptotic targets such as GSK-3 
(Cross et aI., 1995) and caspase-9 (Cardone et aI., 1998), and activating transcriptional 
factors such as NFxB and Forkhead (Kops and Burgering, 1999) in T lymphocytes. 
Results in th¢ first chapter have shown that HNE downregulated Akt phosphorylation 
and activation. In the present study, we found that PTCA pretreatment attenuates 
HNE-induced decreases of Akt activation (Fig. 20). Similarly, NAC, a Cys precursor, 
has been shown to activate Akt and decrease apoptosis in Jurkat T cells by blocking 
adaphostin-mediated ROS generation (Yu et aI., 2004). Others have shown that NAC 
completely reversed N-ethylmaleimide-induced inhibition of Akt phosphorylation and 
apoptosis via inactivation of PP2A in vascular smooth muscle cells (Yellaturu et aI., 
2002). Interestingly, Liu et aI. (2003) showed that pretreatment of the Jurkat T cells 
with Cys before HNE restored the activity of Akt almost to the untreated levels. They 
further demonstrated that inhibition ofPP2A by a PP2A inhibitor, okadaic acid, 
prevented HNE-induced Akt dephosphorylation. It is likely NAC, as well as PTCA, 
reversed ROS induced dephosphorylation of Akt. Thus, PTCA protects against HNE-
78 
induced inactivation ofPI3K1Akt, possibly mediated by restoring phosphorylation of 
Akt kinase through downregulation and association of PP2A. 
GSH is critical for ETV6-NTRK3-transformed murine fibroblast cell growth 
and studies demonstrated that depletion of GSH by BSO inhibited p-Akt 
phosphorylation in these transformed cells (Kim et aI., 2005). In addition, another 
GSH depleting agent, DEM, was shown to inhibit p-Akt expression in rat fibroblast 
cells (Esposito et aI., 2003). In contrast, we have not observed any changes in active or 
total Akt levels in cells treated with BSO for less than 24 h, when 90% of GSH was 
depleted (Figs. 19 and 24). Most of the above experiments were performed by 
exposing cells to different concentrations and conditions of ROS. In our model, we 
treated Jurkat T cells with BSO in a complete (10%) serum RPMI medium; however, 
others starved the fibroblasts for 48 h before DEM addition (1 mM, 30 min). Also, it 
could yield different effects on Akt downregulation via different targets within specific 
cell types such as ETV6-NTRK3 cell, which are especially sensitive to GSH for basal 
cellular functions (Kim et aI., 2005). Interestingly, our results showed that the extent 
of GSH depletion (48 h BSO treatment) and/or second oxidant addition (10 11M MDA) 
inhibited Akt activation either through dephosphorylation or a significant degradation 
of Akt kinase. Together, we and others demonstrated that loss of Akt phosphorylation 
as well as loss of viability was potentiated if the cell sensitized by GSH depletion 
before or after oxidative stress. 
A plot of p-Akt level vs. GSH concentration under different experimental 
conditions (Fig. 20C) shows a similar GSH threshold phenomenon as that of HNE-
induced loss of survival in CD4+ T cells (Fig. 18B). Cells are viable as indexed by p-
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Akt concentration as long as intracellular GSH concentration is maintained at about 
20% of basal levels. This study demonstrated for the first time the close relationship 
between GSH, cytotoxicity, and cell survival. Also the results suggest that the active 
Akt is tightly regulated by intracellular GSH concentration. 
Previously, we reported that PP2A is upregulated promptly under HNE 
treatment and PP2A and Akt simultaneously regulate HNE-induced cytotoxicty, 
however, the mechanism is still not clear. PP2A is a trimeric enzyme composed of a 
catalytic subunit (PP2Ac), a constant regulatory subunit (PR-65 or PP2Aa) and a 
variable regulatory subunit (B, B'B"). It has been suggested that PP2A, as other 
Ser/Thr phosphatases, plays a role in apoptosis (Gjertsen and Doskeland, 1995), 
probably via phosphorylation and dephosphorylation oftarget proteins in the survival 
and/or apoptotic signaling pathways. Our present studies demonstrate for the first 
time, that PTCA pretreatment attenuated HNE-induced increases of PP2A activation in 
lurkat T cells. Analysis of celllysates by antibodies directed at the PP2A regulatory A 
subunit demonstrated the loss of this subunit at 6 h. At the same time, there was less of 
a decrease in the amount of the catalytic subunit (Fig. 21). Similarly, others 
demonstrated that lurkat cells treated with anti-Fas antibody increased PP2A activity 
and protein expression, then caspase-3 inhibitors pretreatment would significantly 
protect against this enhancement (Santoro et aI, 98). Our results and those of others 
suggest the possibility that upregulating PP2A activity is due to cleavage and removal 
of the regulatory A subunit from the core enzyme. Also it suggests that without the 
regulatory A subunit, the catalytic C subunit is still stable in the cytosol. However, our 
results further demonstrate the novelty that PTCA, an antioxidant, inhibits HNE-
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induced PP2A upregulation and Akt downregulation followed by apoptotic cell death is 
regulated by increasing phosphoryaltion of Akt kinase. 
Role of Akt in Fas-mediated signaling 
Akt is involved in the inhibition of Fas-mediated apoptosis by associating with 
intracellular GSH levels, lymphokine and co-stimulatory molecules (Hausler et ai., 
1998). Others have demonstrated that Akt kinase regulates FasL expression and DNA 
fragmentation in vascular smooth muscle cells and cervical cancer (HeLa) cells 
(Suhara et ai., 2002; Uriarte et ai., 2005). Previously, our laboratory showed that Akt 
inhibition by L Y294002 induces FasL expression and subsequent Fas-mediated 
apoptosis in Jurkat T cells (Uriarte et ai., 2005). The present studies showed that 
exposure of T cells to HNE results in inhibiting of Akt activation that leads to Fas-
FasL-dependent apoptosis in Jurkat T cells. However, we observed no increases in 
FasL transcripts at the lower HNE concentration (2.5IlM), which may be due to: 1) 
downregulation of Fas expression in cells or 2) regulation by a posttranscriptional 
mechanism. There are variety of effectors and repressors that lie upstream and 
downstream in the Fas-mediated cell death machinery, along with the recruitment-
activation pathway. This regulation may occur at the level of receptors, such as 
receptor endocytosis or hydrolysis of membrane-bound FasL by metalloproteinase to a 
soluble form. Most importantly, regulation of c-FLIPs plays a role in blocking the 
association of caspase-8 with F ADD in the early stage of signal transduction. c-FLIPs 
is a cytoplasmic protein and has sequence homology with caspase-8, and blocks 
apoptosis by competitively inhibiting caspase-8 in human keratinocytes (Marconi et ai., 
2004). Our results demonstrate that HNE induced Fas-mediated apoptosis also leads to 
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c-FLIPs downregulation. However, the mechanism ofthe antiapoptotic regulation of 
c-FLIPs in T cells treated with HNE is not completely understood. Studies have shown 
that Akt regulates Fas-mediated death signals through c-FLIPs expression in 
endothelial cells (Suhara et aI., 2001). Adenovirus-mediated transfection of 
constitutively active Akt gene abolished homocysteine-mediated downregulation of c-
FLIP in endothelial cells (Suhara et aI., 2004). Others demonstrated that the PI3-kinase 
inhibitor, wortmannin, partially suppressed eicosapentaenoic acid (EP A)-induced c-
FLIPs restoration in endothelial cells (Suzuki et aI., 2003). Together, our result suggest 
that Akt directly upregulated c-FLIPs expression and prevented Fas-mediated 
apoptosis. 
Effect of PTCA on Fas-mediated signaling 
In the present study, we have shown that PTCA restored intracellular GSH 
concentrations, which could then prevent HNE-induced FasL expression both at the 
protein and transcriptional levels (Fig. 22). Others have also found that inhibition of 
tert-butylhydroperoxide (tBH)-induced FasL expression, along with antioxidants GSH 
and NAC, blocked tBH-induced apoptosis in human retinal pigment epithelial cells 
(Jiang et aI., 2000). It is well known that expression of FasL is under redox regulation 
(Kasibhatla et aI., 1999). Upon Fas triggering (a-APO-l) with the antibodies (CH-ll), 
BSO depleted GSH by inhibiting its biosynthesis, increases Fas DISC formation in 
leukemia cells (Friesen et aI., 2004). We further demonstrated that PTCA prevents 
HNE-induced c-FLIPs downregulation, as well as Akt inactivation. To our knowledge, 
this is the first report that GSH plays a role in HNE-induced Fas-mediated apoptosis by 
preventing the loss ofp-Akt and c-FLIPs expression in human T lymphocytes. Others 
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have shown that pretreatment of multiple myeloma cells with NAC or DTT blocked 
oleanane triterpenoid-induced apoptosis and c-FLIPs downregulation (Ikeda et aI., 
2004). Our results clearly indicate that restoration of GSH by PTCA protects against 
HNE-induced Fas-mediated apoptotic cell death, which is mediated through redox 
sensitive Akt and c-FLIPs signaling molecules. 
Overall, our study demonstrates that, in addition to other known antiapoptotic 
functions, GSH regulates Akt kinase in T lymphocytes; this involves the regulation of 
Fas-mediated upstream apoptotic cell death, as well as FasL and c-FLIPs expression. 
PTCA protects against HNE-induced toxicity and could possibly be used in the 
treatment of oxidative stress-induced immunosuppressive diseases. 
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CHPATERIV 
ROLE OF MAT AND SAME IN HNE-INDUCED CYTOTOXICITY 
INTRODUCTION 
The studies of HNE toxicity in human CD4+ T lymphocytes described in this 
chapter were designed to test the possible role of SAMe and MAT II in toxicity. In an 
attempt to assess MAT expression, extractions from HNE treated cells were analyzed 
for MAT II enzymatic activity and gene transcription. To evaluate the role of SAMe 
and GSH in toxicity, the effects of HNE on SAMe concentrations and the ability of 
PTCA protects against HNE-induced MAT downregulation and SAMe depletion were 
determined. To evaluate the role of transcriptional activator of MAT 2A in toxicity, 
the effects of HNE on c-Myb expression and PTCA protection on HNE toxicity were 
examined. 
MATERIALS AND METHODS 
Cell culture 
lurkat T cells were obtained and prepared as described in Chapter II. 
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Chemicals 
SAMe, heptane sulfonic acid, MP A, and SAH were purchased from Sigma 
Chemical Co. (St. Louis, MO). Anti-caspase-3 and p-Actin antibodies were purchased 
from Santa Cruz Biotechnology (Santa Cruz, CA). 
RNA isolation and real time PCR analysis 
Reverse transcriptase polymerase chain reaction (RT-PCR) assays were used to 
assess MAT 2A mRNA levels in Jurkat T cells. The specific primers were designed 
for human GAPDH and MAT 2A using Primer3 software program. The following 





5' TGGGCTACACTGAGCACCAG 3' 
5' GGGTGTCGCTGTTGAAGTCA 3' 
5' ACAATCTACCACCTACAGCCAAGT 3' 
5' GCATAAGAGACCTGAACAAGAACC 3' 
The relative gene expression of MAT2A was analyzed using 2-MCt method as 
described in Chapter II. 
MA T activity assay 
15 x 106 Jurkat cells were homogenized in 500 !!l cold 10 mM Tris-HCI, pH 
7.5, containing 0.3 M sucrose, 0.1 % p-mercaptoethanol, 1 mM benzamidine, 0.1 mM 
PMSF and 10 !!glml soybean trypsin inhibitor. Cells were subjected to 3 cycles of 
freezing/thawing and then were centrifuged (100,000 x g for 30 min) for the extraction. 
An aliquot of 160 !!l from the resulting supernatant was incubated with 90 !!l of 
reaction mixture containing 75 mM Tris-HCI, pH 8, 250 mM KCI, 9 mM MgCh, 10 
mM DTT, 5 mM ATP and 5 mM methionine. The incubation was performed for 30 
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min at 37°C and was stopped by the addition of 70 !-ll 25% MPA ( on ice). Samples 
were centrifuged at 10,000 x g for 2 min. The supernatants were collected for HPLC 
analysis. MAT activity was obtained from the net SAMe formation (subtracted 
intracellular SAMe) and expressed as nmol of SAMe formed per 30 min. 
Analysis of SAMe 
The intracellular concentrations of SAMe were assayed by reverse-phase HPLC 
in deproteinized extracts of cells by a modified method of Merali et aI. (2000). Cell 
pellets were mixed with 0.25 ml of 4% MPA and centrifuged at 10,000 x g for 2 min. 
The supernatants were collected for HPLC analysis. The HPLC system included a 
Waters 501 pump, a manual injector, and a 5 !-lm Hypersil C18 reverse-phase column 
(250 x 4.6 mm). The mobile phase consisted of 40mM ammonium phosphate, 8mM 
heptane sulfonic acid (ion-pairing reagent) and 6% acetonitrile (pH 5.0) and was run 
isocratically at a rate of 1.0 ml/min. SAMe was detected using a Waters 740 detector 
at 254 nm. Standard solutions of SAMe and SAH were prepared in 4% MP A. An 
internal standard, SAE, was added to all samples and standard solutions at a 
concentration of 100 nmol/ml (Merali et aI., 2000; Chen et aI., 1990). 
Western blot analysis 
Following treatment, cells were lysed by immunoprecipitation lysis buffer and 
total cellular proteins (65 !-lg of protein) were resolved on 10% SDS-PAGE and 
subjected to standard immunoblotting procedures. The primary antibodies used in this 
study were as follows: anti-caspase-3 1: 100 and p-Actin 1: 1000. The appropriate 
secondary antibodies were used at 1:5000 for p-Actin and 1: 15,000 for caspase-3. 
Proteins signals were visualized using the ECL system, as directed by the 
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manufacturer. The molecular sizes of the developed proteins were estimated by 
comparison with prestained protein markers. 
Statistical analysis 
Analyses were performed as described in Chapter II. 
RESULTS 
Our previous studies have shown that HNE decreased intracellular SAMe 
concentrations in lurkat T cells. The basal intracellular SAMe concentration was 1.1 ± 
0.14 nmol/mg, and HNE significantly decreased SAMe levels at 6 h. The extent of 
SAMe depletion by HNE (2.5-20 ~M) was about 50% of the control level. 
Interestingly, even at the low HNE (2.5 ~M) concentration, the SAMe levels was 
reduced to 50% of controls. 
HNE decreases MAT II activity 
MAT II is a critical enzyme in cellular metabolism and catalyzes the formation 
of SAMe from L-methionine and ATP. To determine whether HNE induced depletion 
of SAMe is due to an effect on MAT II activity, we measured this enzyme activity. As 
shown in Fig. 25, the MAT II activity of untreated cells was 6.5 ± 0.4 nmol/ml/30min. 
With increasing concentrations ofHNE (2.5, 5, and 10 ~M) MAT II activities were 92, 
55 and 21 %, respectively, of the untreated value. The lowest MAT II activity (1.4 ± 
0.4 nmol/ml/30min) was observed in cells exposed to 10 ~M HNE. These results 
demonstrated that HNE induced a dose-dependent decrease in MAT II activity in 
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Fig. 2S. HNE decreases MAT II activity. lurkat T cells were untreated (UT) or treated 
with various concentrations ofHNE (2.S, S, and 10 11M) for 6 h. MAT II activities were 
assayed at 6 h by the formation of SAMe using HPLC metho d as described in Materi als 
and Methods. Data are represented as mean ± S D of three separate experiments. *P<O.OS 
compared to UT. 
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HNE downregulates MAT 2A gene expression 
Upon T cell activation, a key mechanism for the increase in SAMe biosynthesis 
is increased transcription of MAT 2A, which is a catalytic subunit of MAT gene. We 
further examined the effect of HNE on MAT 2A gene expression. Total RNA was 
isolated from cells exposed to HNE (2.5, 5 and 10 )..lM) for 3 h and MAT 2A mRNA 
levels were assessed by real time PCR. As shown in Fig. 26, MAT 2A mRNA was 
significantly decreased to 0.6-, 0.4- and O.2-fold, respectively, of untreated value. 
HNE was found to decrease MAT 2A mRNA expression in a dose-dependent manner. 
Effects of PTCA on SAMe and MAT 
PTCA, a GSH precursor, has been shown to protect against cytotoxicity in 
CD4+ T lymphocytes. Our previous studies have shown that PTCA markedly 
attenuated HNE-induced decreases in intracellular SAMe concentrations to about 50% 
of the untreated control. PTCA alone had no effect on SAMe concentrations. In lurkat 
T cells pretreated with PTCA, SAMe concentrations were increased to about 90% of 
the untreated control. 
Whether PTCA attenuation of HNE-induced SAMe depletion is related to an 
effect on MAT activity is not known. We examined the effects of PTCA on MAT II 
activity. As shown in Fig. 27, MAT II activity of untreated cells was 6.5 ± 0.4 
nmollml/30min. Treatment of lurkat T cells with increasing concentrations of HNE 
(2.5,5, and 10 )..lM) resulted in MAT II activities that were 93, 55 and 21 %, 
respectively, of the untreated values. In lurkat T cells pretreated with PTCA before the 
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Fig. 26. HNE decreases MAT 2A mRNA levels. Jurkat T cells were prepared as 
described in Fig. 25. Total RNA was isolated at 3 h from cells untreated (UT) or treated 
with HNE (2.5, 5, and 10 flM). MAT 2A mRNA levels were determined by real time 
peR. Data are normalized to the untreated control (which is set to 1) and represented as 













Fig. 27. PTCA attenuates HNE-induced decreases of MAT II activity. lurkat T 
cells were pretreated with PTCA at 250 11M for 1 h before the addition of HNE at 
2.5, 5 or 10 11M. Cells were untreated (UT), or treated with PTCA (250 11M) or 
HNE (2.5, 5, and 10 11M), or PTCA plus HNE. MAT II activities were assayed at 
6 h by the formation of SAMe using HPLC method as described in Materials and 
Methods. Data are represented as mean ± S D of three separate experiments. 
'P<0.05 compared to UT, a.b p<0.05 compared to HNE 5 and 10 11M, respectively. 
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Fig. 28. PTCA attenuates HNE-induced decreases MAT 2A mRNA. Jurkat T 
cells were prepared as described in Fig. 27. Total RNA were isolated from Jurkat 
T cells at 3 h, and MAT 2A mRNA levels were determined by real time PCR. 
Data are normalized to the untreated control (which is set to 1) and represented as 
mean ± SD of four separate experiments. 'p< 0.05 compared to UT, .,b,c P< 0.05 
compared to HNE 2.5, 5 and 10 I-lM, respectively. 
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33 %, respectively, of the untreated value. These results demonstrated that PTCA 
attenuates HNE-induced decreases in MAT II activity. 
Furthermore, a close correlation exists between the GSH concentrations vs. 
MAT II activity (R2=0.9731). As shown in Fig. 29, it appears that there is a threshold 
concentration of GSH of 90-95% depletion before the MAT II activity decreases 
occurred. 
The effect of PTCA on HNE reduced MAT 2A gene expression was further 
investigated. Total RNA was isolated from the cells pretreated with PTCA for 1 h 
before addition of HNE, and MAT 2A rnRNA levels were assessed by real time PCR 
after 3 h. As shown in Fig. 28, MAT 2A mRNA levels were significantly decreased to 
0.6-,0.4- and 0.3-fold, respectively, of untreated value at HNE concentration of 2.5, 5 
and 10 /-lM. In Jurkat T cells pretreated with PTCA before addition of HNE (2.5, 5 and 
10 /-lM), MAT 2A mRNA levels were increased to about 1.8-fold of the untreated 
value. PTCA alone had no effect on MAT 2A mRNA expression. Thus, PTCA 
markedly upregulates HNE-induced decreases on MAT 2A gene expression. 
PTCA vs. c-Myb expression 
Since c-Myb is the transcriptional factor which up-regulates MAT 2A 
expression in activated Jurkat T cells, the effect of HNE on c-Myb expression was 
examined by immunoblot analysis. Similar to the effect of HNE on MAT 2A mRNA 
expression (Fig. 26), HNE was found to downregulate c-Myb in a dose-dependent 
manner (Fig. 30). At the highest concentration (10 /-lM) ofHNE, c-Myb was blocked 
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Fig. 29. Relationship between intracellular GSH concentrations and MAT II 
activity. GSH concentration determined at 3 h and MAT II activity at 6 h after 
HNE treatment. Each point presented value obtained with a given treatment. Plot 
included data from all experiments in cells in which both MAT II activity and 
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Fig. 30. PICA protects against HNE-induced c-Myb expression. Jurkat T cells were 
prepared as described in Fig. 27. Total celllysates were collected at 6 h for Western blot 
analysis as described in Materials and Methods. c-Myb was detected at 6 h by 
immunoblotting using an anti -c-Myb antibody. Blots were stripped and reprobed with 
antibody to (3- actin to ensure equivalent loading. A representative gel out of three 
experiments is shown. 
downregulation. PTCA alone slightly increased expression of c-Myb. The results 
suggested that c-Myb is downregulated by HNE and PTCA protected against c-Myb 
downregulation, thus it is probably mediated by a redox sensitive transcription factor. 
PTCA vs. Caspase-3 activation 
Our previous studies have shown that PTCA, a GSH precursor, protects against 
HNE-induced cytotoxicity and apoptotic cell death. In lurkat T cells pretreated with 
PTCA, DNA fragmentation, an index of apoptosis, was decreased to about 1.8-fold of 
the untreated value as compared to 2.5-fold decrease in cells treated with HNE alone 
(previous study). 
Caspase-3 is the main executioner caspase, and its activation plays a critical 
role in downstream apoptosis signaling and leads to DNA fragmentation. We 
examined caspase-3 activation in lurkat T cells treated with HNE (2.5, 5 and 10 [!M) 
alone 1 h following pretreated with PTCA. As shown in Fig. 31, HNE-induced a 
significant activation of caspase-3 by increasing the cleavages from procaspase-3 (at 
32KDa) to active caspase (at p17-20KDa) in a dose-dependent manner. PTCA 
pretreatment protected against the cleavage of procaspase-3. Additionally, PTCA 
produced no increase in cleavage products, suggesting that PTCA had no effect on 
caspase-3 activation. The results showed that HNE-induces caspase-3 dependent 
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Fig. 31. PTCA protects against HNE-induced caspase-3 dependent apoptosis. lurkat T 
cells were prepared as described in Fig. 27. Total celllysates were collected at 8 h for 
Western blot analysis as described in Materials and Methods. Untreated cells (UT) were 
used as a negative control. Pro (32KDa) and active (20KDa) caspase-3 was detected at 8 h 
by immunoblot ting analysis. Blots were stripped and reprobed with antibody to ~-actin to 
ensure equivalent loading. A representative gel out of three experi ments is shown. 
DISCUSSION 
Methionine adenosyltransferase (MAT, EC 2.5.1.6) is the rate limiting enzyme 
that catalyzes the biosynthesis of SAMe from L-methionine and ATP (Cantoni, 1953). 
Various studies have shown the relevance and importance of SAMe and MAT in 
oxidative stress-induced hepatic damage (Lu, 2000). Administration of BSO, an 
inhibitor of GSH biosynthesis, leads to a 60% decrease of hepatic MAT activity in 
Wistar rats (Corrales et aI., 1991). APAP administration induced a 72% suppression of 
MAT activity concomitant with GSH depletion in Swiss-Webster mice (Shirota et aI., 
2002). Clinically, patients with alcoholic cirrhosis have decreased SAMe biosynthesis 
due to decreased expression of MAT 1A and hepatic MAT activity (Mato et aI., 2002). 
Previously, our laboratory has shown that ethanol treatment produced a significant 
reduction of MAT 2A and MAT II in MOLT -4 and lurkat T cells. These notions led 
us to study whether MAT II could be targeted by oxidative agents, such as the lipid 
peroxidation end products, and HNE in different tissues, such as lymphocytes. Along 
with similar results in liver from other studies, we were the first to observe that HNE 
treatment effectively inhibited MAT II activity in a dose dependent manner in lurkat T 
cells. 
The MAT 2A gene encodes the MAT II isozyme and is expressed wildely in all 
tissues including fetal and transformed hepatocytes and cells such as erythrocytes and 
lymphocytes (Kotb and Kredich, 1985). MAT 2A gene expression is deeply 
influenced by the cell cycle and is correlated with cell proliferation (De La Rosa et aI., 
1995). Consistent with this finding, studies have shown that IL-2 and phorbol ester 
stimulated MAT 2A expression in lurkat T cells (LeGros et aI., 1997). Dexamethasone 
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(DEX), a known inhibitor of T-Iymphocyte activation, blocked IL-2 and phorbol12-
myristate 13-acetate (PMA)-mediated regulation of MAT 2A expression. Interestingly, 
DEX treatment alone had no effect on the basal mRNA level of MAT 2A (Zeng et aI., 
2001). Our results showed that not only does HNE significantly inhibit MAT II 
activity, but this decrease correlated with the decay in MAT 2A mRNA levels. Thus, 
these results suggest that the MAT 2A gene is targeted by HNE. 
SAMe, as a methyl donor, is involved in the production of nucleic acids (DNA 
and RNA), proteins, neurotransmitters, hormones, and phospholipids, and it functions 
as an antioxidant. SAMe is also required for cell proliferation. In fact, upon activation 
of T -lymphocytes, both the SAMe pool size and the rate of SAMe utilization increase 
and is accompanied by induction of MAT 2A and MAT II (Honchel et aI, 1992; De La 
Rosa et aI., 1992). Most importantly, the inhibition of SAMe biosynthesis blocks T 
cell proliferation (German et aI., 1983; Kotb and Geller, 1993). SAMe also functions 
as a GSH precursor through the transsulfuration pathway. Studies have shown that 
decreases in SAMe result in GSH deficiency under oxidative stress (Honchel et aI, 
1992; Wang and Spitzer, 1997). An increased flux of 13C-Iabeled methionine into S-
adenosylhomocysteine (SAH) in human lung epithelial-like (A549) cells demonstrated 
the utilization of SAMe. In addition, the formation of cystathionine increased, 
indicating that at least part of the SAMe generated was directed toward cysteine/GSH 
in the transsulfuration pathway (Panayiotidis et aI., 2006). Our previous work 
demonstrated that HNE significantly decreased intracellular SAMe and GSH 
concentrations. Compared with the time course of GSH depletion (previous studies) 
and to Fas-mediated apoptotic signaling, HNE decreased intracellular SAMe at a later 
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time point (6 h, previous study). These results suggest that SAMe depletion occurs: 1) 
at least in part, when there is an inhibition of methionine breakdown at the level of the 
SAMe synthesis; 2) after the extensive utilization of GSH through the transsulfuration 
pathway by HNE. The concomitant decrease in hepatic SAMe and GSH 
concentrations was also observed in alcoholic patients and chronic alcoholic diet feed 
animal models (Sprague-Dawley rats) (Koch et aI., 1991; Honchel et aI, 1992; Wang 
and Spitzer, 1997). 
Rest(J>ration of intracellular SAMe levels has been shown to playa role in 
maintaining MAT 1A gene expression and protecting against cytotoxicity in rat 
hepatocytes, suggesting it is a "proof of concept" supplementation (Lu and Mato, 
2005). However, there are several disadvantages using SAMe supplementation 
directly whiah include: 1) difficulty in crossing membranes; 2) low biological 
availability by oral or parenteral administration; 3) two biological isomers (the inactive 
R,S and the active S,S forms) in the medium; 4) high cost. Our preliminary study has 
shown that SAMe pretreatment potentiated HNE induced cytotoxicity in Jurkat T cells, 
though the aSH and SAMe concentrations were increased. Others observed a rapid 
elevation of serum aminotransferases such as ALT and AST during SAMe treatment of 
patients with liver diseases. Thus, SAMe administration is considered to be 
controversial. 
In thils study, we observed the effect of PTCA, a GSH precursor, on 
intracellular SAMe concentration. PTCA has been shown to block APAP-induced 
GSH depletion and hepatotoxicity in rats and mice (Song, 1994; Fu, 2001). PTCA 
functions similar to NAC by supplying Cys for GSH synthesis in a prodrug form; but 
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PTCA releases Cys independently from enzymatic hydrolysis. We have shown that 
PTCA attenuated GSH depletion, thereby preventing HNE toxicity in lurkat T cells. 
Shirota et aI. (2002) have shown that NAC attenuates APAP-induced hepatic depletion 
of GSH and SAMe in Swiss-Webster mice by maintaining MAT activity. Others have 
also shown that GSH concentration regulates MAT activity in rat liver during 
ischemia-reperfusion (Ito et aI., 1999). Together, PTCA significantly restores SAMe 
concentration in lurkat T cells possibly through the transsulfuration pathway. 
A plot of MAT II activity vs. GSH concentration under different experimental 
conditions (Fig. 29) shows a similar GSH threshold phenomenon as that of HNE-
induced loss of survival and p-Akt level in CD4+ T lymphocytes (Figs. 18 and 20). 
These and earlier results support the concept that a reduction in GSH to 20% of control 
levels may be critical for cell survival. HNE-mediated decreases in intracellular GSH 
concentrations could then result in an inactivation of MAT II as well as decrease 
SAMe levels. 
Our results further demonstrated a 2 to 3-fold increase on MAT 2A mRNA in 
lurkat T cells pretreated with PTCA, compared to HNE alone. Others have shown that 
NAC and PTCA attenuate APAP-induced decreases of MAT activity in Swiss-Webster 
mice (Shirota et aI., 2002). Administration of the antioxidant coenzyme Q 1 0 to rats 
prior to ischemia protected against both the reductions in MAT activity and the hepatic 
GSH level induced by ischemia-reperfusion (Ito et aI., 1999). In A549 and lurkat cells, 
MAT 2A mRNA levels were significantly increased during hyperoxia (95% O2) (Ito et 
aI., 1999; Zeng et aI., 2001). Together, these results directly support the important role 
GSH plays in the activation of the MAT 2A and the MAT II enzyme which is redox 
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sensitive reaction. Further, we observed the involvement of the transsulfuration 
pathway in the metabolic response to HNE in lurkat T cells. 
The effect of HNE on the MAT 2A gene expression is likely to be a result of its 
effect on the MAT 2A transcriptional regulator, c-Myb. c-Myb is a 75- to 80-KDa 
protein that functions as a transcriptional regulator for cell proliferation, differentiation, 
and survival during hematopoiesis (Oh and Reddy, 1999). The mutated c-Myb site 
located at -350 to -333 on the MAT 2A promoter was shown to abolish the induction of 
MAT 2A promoter activity and c-Myb nuclear-binding activity mediated by IL-2 and 
phorbol ester in lurkat cells (Zeng et aI., 2001). In contrast, overexpression c-Myb in 
quiescent lurkat T cells increased MAT 2A promoter activity, suggesting c-Myb plays 
an important role in upregulating MAT 2A expression during T cell expansion 
(Venturelli et aI., 1990; Furukawa et aI., 1990). Although multiple gene targets 
regulated by c-Myb transactivation have been identified in T lymphocytes (Andersson 
et aI., 1999), there is little information on genes that are relevant for CD4+ T 
lymphocyte survival. Studies have shown that 1 IlM HNE inhibited c-myb mRNA at 1 
h whereas 10 IlM HNE inhibited c-Myb expression at 3-6 h in leukemia HL-60 cells 
(Barrera et aI., 1996). Similarly, our results showed that c-Myb expression decreased 
dose-dependently from 2.5 IlM and were completely blocked at 6 h after treated with 
10 IlM HNE (Fig. 31). All together, these results demonstrate that HNE-induced 
downregulation of MAT 2A gene expression occurs through a decrease of c-Myb. 
This finding suggests that the MAT 2A gene is directly associated with T cell survival 
and is an important target gene for c-Myb in the regulation of T cell growth. 
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Additionally, studies have shown the c-Myb protein that is bound specifically 
to DNA fragments is negatively regulated by phosphorylation of the amino-terminus 
with the protein kinase CKII (Oelgeschlager et aI., 1995). This suggests DNA-binding 
may be regulated by secondary protein modifications. Others have shown that c-myb 
transcription is activated by protein kinase B following IL-2 stimulation and is required 
for PKBIPI3K-mediated protection from apoptosis in T cells (Lauder et aI., 2001). 
Also it is known that c-Myb activity is required for Akt, a survival factor, during T cell 
activation and that the c-Myb gene is regulated only by components of the PI-3K 
pathway (Lauder et aI., 2001). Based on our PTCA results, the mechanism of 
upregulation of c-Myb might possibly be through multiple pathways and may include 
increased redox restoration and kinase phosphorylation. 
Both intracellular antioxidant concentrations (GSH and SAMe) and c-Myb have 
been shown to be important regulators for cell proliferation and survival in CD4+ T 
lymphocytes (German et aI., 1983; Venturelli et aI., 1990). However, fewer studies 
have investigated the association of GSHISAMe and c-Myb. Our results are the first to 
show that the restoration of endogenous antioxidant concentrations by PTCA 
influences the expression of c-Myb in vitro (Fig. 31). As a transcription factor, the 
DNA binding activity of c-Myb is suggested to be regulated by a reduction-oxidation 
mechanism. Oxidation by diamide of the Myb-proteins in vitro inhibits their 
interaction with DNA, whereby the diamide effect is reversible by supplementation 
with reducing agents such as DTT (Guehmann et aI., 1992). 
Since SAMe and MAT are critical for CD4+ T lymphocytes survival and 
proliferation, downregulation effects of HNE on MAT II expression and activity and 
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consequent SAMe deficiency may lead to apoptotic T cell death. During apoptosis, 
caspase-3 has been demonstrated to cleave vital proteins such as poly (ADP-ribose) 
polymerase (PARP) and to amplify upstream caspase signals leading to DNA 
fragmentation at the end stage of apoptosis (Liu et aI., 2000). Our previous work 
characterized HNE-mediated CD4+ T cell apoptosis by recruiting procaspase-8, an 
initiating caspase, to DISC through FaslFasL pathway in the early stage and thereby 
activating a series of caspase cascades. In the present study, we demonstrated that 
inhibition of SAMe biosynthesis by HNE led to activation of caspase-3. Recently, our 
laboratory has shown that cycloleucin, a MAT inhibitor, significantly increases 
caspase-3 and -8 cleavages and leads to DNA fragmentation. More importantly, we 
demonstrated for the first time that PTCA can attenuate HNE-induced caspase-3 
activation (Fig. 31), along with its protection against HNE-induced apoptosis in CD4+ 
T cells. Other antioxidant such as NAC was also shown to block HNE-induced 
caspase-3 activation and DNA fragmentation in Jurkat T cells (Liu et aI., 2000). 
Further, pretreatment of Jurkat T cells with anethole dithiolethione (10-50 rnM, 18 h) 
restored HNE-induced cytotoxicity (Khanna et aI., 1998). Thus, our results confirmed 
findings of others on the protective effect of antioxidants and suggest that PTCA 
protects against HNE-induced caspase-3 activation and caspase-3 dependent apoptosis, 
possibly through GSH restoration. 
In conclusion, we have identified MAT II and SAMe are critical molecular 
components required for CD4+ T cell survival, and HNE downregulates MAT II 
expression and activity resulting in SAMe depletion. Based on these findings, we 
postulate that investigation of the effects of HNE on CD4+ T cell MATII activity, 
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SAMe levels, and survival will provide important information concerning mechanisms 
of immunosuppression. Additionally, attenuation of HNE-induced apoptotic T cell 
death by GSH prodrug (PTCA) provides a potential therapeutic use in treating immune 
dysfunction associated with other immnunosuppressive disorders such as HIV/HCV 
infection and diabetes. 
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CHAPTER V 
SUMMARY AND CONCLUSION 
The principle hypotheses of the project were that 1) human CD4+ T 
lymphocytes (Jurkat) would be susceptible to HNE-induced cytotoxicity but 
relatively resistant to MDA, 2) HNE-induced cytotoxicity involves an early 
formation of DISC, which is Fas-FasL -dependent pathway and can be detoxified 
by restoration of GSH and concomitant activation of Akt kinase, 3) and that 
SAMe depletion and MAT II downregulation by HNE might be involved in 
HNE-induced cytotoxicity. 
Summary of results 
1. HNE inhibits Akt activation, enhances FasL expression, and induces 
DISC formation with increased binding of FADD leading to caspase-8 
activation 
2. DISC formation and caspase-8 activation are critical initiating events in 
the HNE induced Fas-mediated apoptotic death in CD4+ T lymphocytes. 
3. HNE causes dose dependent Akt downregulation and PP2A upregulation, 
concomitantly, both are regulated by GSH. 
4. HNE causes dose- and time-dependent decreases in intracellular GSH 
concentrations. 
106 
5. PTCA, a GSH precursor, attenuates HNE-induced intracellular GSH 
depletion and protected against HNE-induced Fas-mediated apoptotic cell 
death through Akt and c-FLIPs. 
6. BSO, a GSH depleting agent, increases sensitization to lipid peroxidation 
and potentiates cytotoxicity by Akt inactivation and dephosphorylation. 
7. MAT II and SAMe are critical molecular targets affected by HNE in CD4+ T 
lymphocytes. 
8. HNE down-regulates MAT II activity and MAT 2A expression resulting in 
intracellular SAMe depletion in CD4+ T lymphocytes. 
9. A close correlation was established between GSH, cytotoxicity, survival 
factor and MAT II activity. 
10. HNE down-regulates c-Myb expression, which is a transcription activator 
ofMAT2A. 
11. PTCA restores intracellular SAMe levels, MAT II activity, upregulates MAT 2A 
and c-Myb expression and prevents HNE-induced caspase-3 dependent 
apoptotic cell death. 
Conclusion 
1. A complete signaling pathway on HNE-induced cytotoxicity was 
established. 
2. A critical threshold level of GSH was found to be associated with HNE 
induced cytotoxicity, decreases p-Akt activity, and inhibition of MAT II 
activity and PTCA can protect against these. 
3. PTCA may be beneficial in the treatment of immunosuppressive disorders 
involving CD4 + T cell depletion, such as HIV and HCV infection. 
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LIST OF ABBREVIATIONS 
ADT, anethole dithiolethione 
AICD, activation-induced cell death 
AP AP, acetaminophen 
ASKl, apoptosis signal-regulating kinase 1 
BSO, buthionine sulfoximine 
Cys, L-cysteine 
DISC, death-inducing signaling complex 
DEM, diethyl maleate 
DTT, dithiolthreitol 
EPA, eicosapentaenoic acid 
ECL, enhanced chemiluminescence 
FADD, Fas-associated death domain 
FasL, Fas ligand 
FLICE, FADD-like interleukin 1 l3-converting enzyme 
FLIP, FLICE inhibitory protein 
GSK3, glycogen synthase kinase 3 
GSH, glutathione 
GSSG, glutathione disulfide 
HIV, human immunodeficiency virus 
HO-l, heme oxygenase 1 
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HNE, 4-hydroxynonenal 
HPLC, high performance liquid chromatography 
H20 2, hydrogen peroxide 
LDH, lactate dehydrogenase 
MAT, methionine adenosyltransferase 
MDA, malondialdehyde 
MP A, monochloroacetic acid 
MPP+, methylpyridinium 
NF"B, nuclear factor-kappa B 
NAC, N-acetyl-cysteine 
OTC, L-2-0xothiazolidine 4-carboxylate 
PAP, para-aminophenol 
PBS, phosphate buffered saline 
PD K 1, phosphoinositide-dependent kinase-l 
PHA, phytohemagglutinin 
PMA, phorbol 12-myristate 13-acetate 
PMSF, phenylmethylsulphonylfluoride 
PP2A, protein phosphatase-2A 
PTCA, 2(RS)-n-Propylthiazolidine-4(R)-carboxylic acid 
SAH, S-adenosylhomocysteine 
SAMe, S-Adenosyl-methionine 
SDS-PAGE, sodium dodecyl solfate-polyacrylamide gel electrophoresis 
119 
CURRICULUM VITAE 
NAME: Wei-Yuan Chang 
ADDRESS: Department of Pharmacology and Toxicology 
School of Medicine, University of Louisville 
Louisville, KY 40292 
BORN: Taipei, Taiwan - Aug 12, 1977 
EDUCATION & TRAINING: 
1992-1995 Wesley Girls High School, Taipei, Taiwan 
1995-2000 B.S. Taipei Medical University, Taipei, Taiwan 
2001-2004 M.S. University of Louisville, Louisville, Kentucky 
2004-present Ph. D. Pharmacology and Toxicology, 
PRESENT POSITION: 
University of Louisville, Louisville, Kentucky (expected) 
Dissertation title: Mechanism of 4-Hydroxynonenal 
Toxicity in lurkat CD4+ T Lymphocytes 
Graduate student; Department of Pharmacology and Toxicology 
University of Louisville 
120 
